No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
496 |
4. Check minimum number of eventsNone |
496 |
5. Include endpointsNone |
496 |
6. Filter based on genotype QC (FinnGen only) |
471 |
Control definitions (FinnGen only)
- Control exclude
- J10_INTERSTITIUM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF6
- Parent code in ICD-10
- J80-J84
- Name in latin
- Syndroma dyspnoicum adultorum
Similar endpoints
↥List of similar endpoints to
Adult respiratory distress syndrome
based on the number of shared cases.
Similar with more cases:
- Other respiratory diseases principally affecting the interstitium
- Condition for Implicit Sepsis (Organ dysfunction codes)
- Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo
- Diseases of the respiratory system
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4454 | 1675 | 2699 |
| Only index persons | 2675 | 1057 | 1618 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.05 | 0.08 |
| Only index persons | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 64.11 | 63.05 | 64.59 |
| Only index persons | 63.57 | 61.33 | 65.04 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 471 | 171 | 300 |
| Unadjusted period prevalence (%) | 0.11 | 0.06 | 0.14 |
| Median age at first event (years) | 63.42 | 55.98 | 67.66 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 496
- Matched controls
- 4960
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J80
ICD-10 Finland
Adult respiratory distress syndrome
+∞
307.7
474
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
6.2
89.3
313
1077
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.0
83.4
219
580
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.8
65.6
121
225
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.8
60.9
137
307
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
9.1
58.7
78
100
WX730
NOMESCO Finland
Conventional respirator
19.0
52.1
42
24
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
515.0
48.2
47
*
WX872
NOMESCO Finland
Intensive care
6.8
48.2
83
142
GD1AD
NOMESCO Finland
Thorax CT examination
5.7
38.3
79
160
GBB00
NOMESCO Finland
Tracheostomy
15.1
37.7
34
24
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
+∞
34.8
33
*
J96.0
ICD-10 Finland
Acute respiratory failure
12.5
33.7
34
29
TK800
NOMESCO Finland
Hemodialysis
9.2
32.7
41
48
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.6
31.2
82
203
TGC00
NOMESCO Finland
Bronchial lavation
7.6
28.0
41
58
WX892
NOMESCO Finland
Monitored bed care
4.3
26.6
77
205
L04AA06
ATC
mycophenolic acid; systemic
10.2
25.2
29
30
ZXD05
NOMESCO Finland
Urgent procedure
2.7
24.9
207
1038
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.5
24.6
65
161
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.3
24.5
37
54
A41.9
ICD-10 Finland
Sepsis, unspecified
5.4
24.3
50
100
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.7
24.2
61
145
5185A
ICD-9 Finland
Other diseases of lung, Pulmonary insufficiency following trauma and surgery
+∞
23.1
22
*
J01MA12
ATC
levofloxacin; systemic
2.7
21.2
144
644
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
+∞
19.9
19
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.8
19.1
36
66
WX882
NOMESCO Finland
High dependency care
6.0
18.3
33
58
H02AB06
ATC
prednisolone; systemic
2.3
18.1
279
1780
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
17.9
92
352
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
17.7
145
704
C03CA01
ATC
furosemide; systemic
2.3
17.5
226
1336
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
17.5
97
387
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
17.0
98
398
WX725
NOMESCO Finland
Noninvasive ventilation
4.0
16.9
50
134
J81
ICD-10 Finland
Pulmonary oedema
+∞
16.8
16
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
6.1
15.9
28
48
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
15.7
15.0
24
16
JN4BD
NOMESCO Finland
Extensive body CT
2.8
14.8
81
319
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.8
14.7
83
332
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
6.8
14.6
23
35
A98
ICPC
Health maint/preventive medicine
0.5
14.5
334
4071
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
13.9
276
1874
R50.9
ICD-10 Finland
Fever, unspecified
2.5
13.7
100
455
J01MA14
ATC
moxifloxacin; systemic
2.9
13.6
71
272
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
13.4
76
305
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
13.0
84
359
127
Kela drug reimbursment
Transplant complication
11.4
12.6
23
21
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
17.9
12.6
19
11
J96.1
ICD-10 Finland
Chronic respiratory failure
4.8
12.3
28
61
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.7
12.2
40
115
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
21.9
12.1
17
8
WX722
NOMESCO Finland
PEEP
3.3
11.8
47
154
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.5
11.6
42
129
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
11.4
61
236
I50.9
ICD-10 Finland
Heart failure, unspecified
2.2
11.4
117
612
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.9
11.3
25
53
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
5.7
11.3
21
38
XG410
NOMESCO Finland
Flow-volume spirometry
3.9
11.2
33
88
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.9
10.6
32
87
N05AA02
ATC
levomepromazine; systemic
3.7
10.4
34
98
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
4.6
10.1
24
54
A10AC01
ATC
insulin (human); parenteral
2.7
10.0
58
234
WX704
NOMESCO Finland
Intubation
2.9
10.0
50
187
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.4
9.9
36
111
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.3
9.8
38
122
L04AX01
ATC
azathioprine; systemic
4.2
9.8
26
64
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
4.1
9.7
27
69
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.5
9.6
63
270
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
9.6
137
805
Z2446
NOMESCO Finland
Social worker
2.9
9.5
45
163
B01AA03
ATC
warfarin; systemic
2.0
9.5
131
762
WX726
NOMESCO Finland
High-flow oxygen therapy
+∞
9.4
9
*
N03AX16
ATC
[U] pregabalin
2.0
9.3
125
718
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.8
9.3
28
76
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.4
9.2
33
101
A01AB10
ATC
natamycin; local oral
4.6
9.2
22
50
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
9.1
128
747
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
8.9
95
502
Z3226
NOMESCO Finland
Physiotherapist
2.1
8.9
102
554
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
8.6
91
479
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
8.5
157
998
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.4
8.5
30
91
TQW11
NOMESCO Finland
Vacuum treatment of wound
4.6
8.4
20
45
R06.0
ICD-10 Finland
Dyspnoea
1.8
8.4
154
977
ZX120
NOMESCO Finland
Intravenous
2.4
8.4
62
281
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
7.7
8.2
18
24
A10AB05
ATC
insulin aspart; parenteral
2.6
8.2
49
201
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
17.5
8.1
12
7
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
8.0
136
841
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.3
7.8
20
48
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.3
7.8
29
91
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
3.5
7.6
26
77
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.9
7.6
22
58
J15.8
ICD-10 Finland
Other bacterial pneumonia
9.6
7.3
14
15
284
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
7.3
7
*
R03BB04
ATC
tiotropium bromide; inhalant
2.1
7.2
72
369
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.0
7.2
20
51
XG466
NOMESCO Finland
Sleep oxymetry
3.5
7.2
25
75
L04AD01
ATC
ciclosporin; systemic
6.7
7.2
17
26
RS220, ,
NOMESCO Finland
10.2
7.1
13
13
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.3
7.1
18
43
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.5
7.1
47
203
K85
ICD-10 Finland
Acute pancreatitis
4.5
7.0
17
39
K65.0
ICD-10 Finland
Acute peritonitis
7.7
6.9
15
20
J12.8
ICD-10 Finland
Other viral pneumonia
8.4
6.9
14
17
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.0
6.8
78
422
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.0
6.7
29
100
GX2D5
NOMESCO Finland
Sleep oximetry
22.9
6.7
9
*
H02AB04
ATC
methylprednisolone; systemic
2.0
6.7
81
446
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
5.6
6.7
18
33
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.5
6.7
42
177
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.4
6.6
23
69
J93.8
ICD-10 Finland
Other pneumothorax
10.2
6.6
12
12
Z94.0
ICD-10 Finland
Kidney transplant status
10.2
6.6
12
12
N17.8
ICD-10 Finland
Other acute renal failure
7.0
6.6
15
22
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.0
6.5
28
96
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.3
6.5
16
26
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.5
6.4
14
19
137
Kela drug reimbursment
Uraemia requiring dialysis
9.4
6.3
12
13
JN4AD
NOMESCO Finland
Body CT examination
2.0
6.3
68
359
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.2
6.3
25
82
356
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
6.3
6
*
P01BA02
ATC
hydroxychloroquine; oral
2.4
6.2
41
177
C07AB07
ATC
bisoprolol; oral
1.6
6.2
262
2042
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.4
6.1
41
178
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.6
6.1
36
147
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
8.8
6.1
12
14
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.8
6.1
14
21
ZXD00
NOMESCO Finland
Emergency procedure
3.4
6.1
21
63
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
10.2
6.1
11
11
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
1.3e+00
2.4e+00
4.8e+00
1.0e+50
4.5e+00
2.8e+00
1.6e+00
cases:9.76%
controls:2.79%
cases:9.96%
controls:0.98%
cases:21.34%
controls:0.22%
cases:26.02%
controls:0.00%
cases:16.53%
controls:0.22%
cases:19.52%
controls:1.51%
cases:20.63%
controls:5.19%
48
137
444
4774
49
48
443
4863
105
11
387
4900
128
0
364
4911
59
11
298
4898
57
73
235
4752
52
214
200
3907
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
1.4e+00
2.5e+00
4.7e+00
1.0e+50
4.7e+00
2.5e+00
1.4e+00
cases:5.08%
controls:1.30%
cases:6.71%
controls:0.59%
cases:10.37%
controls:0.10%
cases:6.91%
controls:0.00%
cases:10.08%
controls:0.10%
cases:7.19%
controls:0.60%
cases:10.71%
controls:2.79%
25
64
467
4847
33
29
459
4882
51
5
441
4906
34
0
458
4911
36
5
321
4904
21
29
271
4796
27
115
225
4006
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
9.1e-01
2.1e+00
4.9e+00
1.0e+50
4.5e+00
1.9e+00
1.2e+00
cases:7.52%
controls:3.16%
cases:10.16%
controls:1.38%
cases:16.26%
controls:0.14%
cases:10.57%
controls:0.00%
cases:14.57%
controls:0.18%
cases:9.93%
controls:1.68%
cases:16.27%
controls:5.63%
37
155
455
4756
50
68
442
4843
80
7
412
4904
52
0
440
4911
52
9
305
4900
29
81
263
4744
41
232
211
3889
Pulmonary Disease
29 [38004472]
29 [38004472]
7.8e-01
1.7e+00
3.2e+00
—
3.8e+00
2.9e+00
1.8e+00
cases:17.68%
controls:9.00%
cases:21.75%
controls:4.62%
cases:17.68%
controls:0.90%
—
—
cases:25.21%
controls:0.73%
cases:45.21%
controls:4.41%
cases:40.08%
controls:9.68%
87
442
405
4469
107
227
385
4684
87
44
405
4867
—
90
36
267
4873
132
213
160
4612
101
399
151
3722
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
9.8e-01
1.7e+00
3.6e+00
—
3.8e+00
2.5e+00
1.3e+00
cases:16.87%
controls:7.11%
cases:16.67%
controls:3.44%
cases:11.18%
controls:0.35%
—
—
cases:10.92%
controls:0.26%
cases:25.34%
controls:2.84%
cases:27.38%
controls:9.00%
83
349
409
4562
82
169
410
4742
55
17
437
4894
—
39
13
318
4896
74
137
218
4688
69
371
183
3750
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
1.1e+00
1.8e+00
3.5e+00
1.0e+50
4.1e+00
2.0e+00
1.2e+00
cases:5.89%
controls:2.08%
cases:5.89%
controls:0.98%
cases:5.28%
controls:0.16%
cases:1.42%
controls:0.00%
cases:10.92%
controls:0.20%
cases:6.51%
controls:0.95%
cases:9.52%
controls:2.94%
29
102
463
4809
29
48
463
4863
26
8
466
4903
7
0
485
4911
39
10
318
4899
19
46
273
4779
24
121
228
4000
Nephrology
39 [38004479]
39 [38004479]
1.6e+00
2.0e+00
2.6e+00
—
3.3e+00
2.4e+00
1.8e+00
cases:3.05%
controls:0.65%
cases:4.07%
controls:0.57%
cases:1.63%
controls:0.12%
—
—
cases:2.80%
controls:0.10%
cases:5.82%
controls:0.58%
cases:5.95%
controls:1.07%
15
32
477
4879
20
28
472
4883
8
6
484
4905
—
10
5
347
4904
17
28
275
4797
15
44
237
4077
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
7.9e-01
1.9e+00
4.3e+00
1.0e+50
3.3e+00
1.9e+00
1.1e+00
cases:7.72%
controls:3.64%
cases:6.30%
controls:1.02%
cases:6.71%
controls:0.10%
cases:6.10%
controls:0.00%
cases:2.80%
controls:0.10%
cases:5.82%
controls:0.89%
cases:10.71%
controls:3.93%
38
179
454
4732
31
50
461
4861
33
5
459
4906
30
0
462
4911
10
5
347
4904
17
43
275
4782
27
162
225
3959
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
1.3e+00
1.9e+00
3.4e+00
—
3.3e+00
1.8e+00
1.2e+00
cases:6.10%
controls:1.77%
cases:5.89%
controls:0.92%
cases:3.66%
controls:0.12%
—
—
cases:3.64%
controls:0.14%
cases:6.51%
controls:1.12%
cases:6.75%
controls:2.21%
30
87
462
4824
29
45
463
4866
18
6
474
4905
—
13
7
344
4902
19
54
273
4771
17
91
235
4030
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
28541-1 [3002179]
1.4e+00
1.5e+00
3.6e+00
—
3.2e+00
1.8e+00
1.3e+00
cases:2.44%
controls:0.61%
cases:2.24%
controls:0.53%
cases:3.66%
controls:0.10%
—
—
cases:3.92%
controls:0.16%
cases:3.08%
controls:0.50%
cases:4.37%
controls:1.21%
12
30
480
4881
11
26
481
4885
18
5
474
4906
—
14
8
343
4901
9
24
283
4801
11
50
241
4071
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
2.1e+00
2.5e+00
—
—
3.5e+00
2.8e+00
1.8e+00
cases:5.08%
controls:0.65%
cases:4.47%
controls:0.37%
—
—
—
—
cases:3.36%
controls:0.10%
cases:4.79%
controls:0.29%
cases:5.95%
controls:1.04%
25
32
467
4879
22
18
470
4893
—
—
12
5
345
4904
14
14
278
4811
15
43
237
4078
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
1.8e+00
2.7e+00
4.4e+00
1.0e+50
—
2.6e+00
1.3e+00
cases:4.07%
controls:0.71%
cases:5.69%
controls:0.41%
cases:7.52%
controls:0.10%
cases:3.86%
controls:0.00%
—
—
cases:5.48%
controls:0.41%
cases:7.54%
controls:2.18%
20
35
472
4876
28
20
464
4891
37
5
455
4906
19
0
473
4911
—
16
20
276
4805
19
90
233
4031
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
8.3e-01
1.8e+00
3.3e+00
—
3.4e+00
2.0e+00
1.2e+00
cases:16.46%
controls:7.92%
cases:11.38%
controls:2.16%
cases:8.94%
controls:0.37%
—
—
cases:12.61%
controls:0.47%
cases:14.04%
controls:2.11%
cases:21.83%
controls:7.43%
81
389
411
4522
56
106
436
4805
44
18
448
4893
—
45
23
312
4886
41
102
251
4723
55
306
197
3815
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
5.5e-01
1.0e+00
2.2e+00
4.6e+00
2.3e+00
1.0e+00
7.8e-01
cases:14.02%
controls:8.57%
cases:12.60%
controls:5.05%
cases:13.01%
controls:1.63%
cases:9.35%
controls:0.10%
cases:13.73%
controls:1.57%
cases:13.36%
controls:5.22%
cases:22.22%
controls:11.55%
69
421
423
4490
62
248
430
4663
64
80
428
4831
46
5
446
4906
49
77
308
4832
39
252
253
4573
56
476
196
3645
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
1.2e+00
1.4e+00
3.0e+00
—
3.3e+00
2.2e+00
1.2e+00
cases:7.11%
controls:2.36%
cases:3.46%
controls:0.83%
cases:2.44%
controls:0.12%
—
—
cases:2.80%
controls:0.10%
cases:6.85%
controls:0.81%
cases:9.92%
controls:3.30%
35
116
457
4795
17
41
475
4870
12
6
480
4905
—
10
5
347
4904
20
39
272
4786
25
136
227
3985
Inpatient Hospital
21 [8717]
21 [8717]
7.2e-01
1.4e+00
3.4e+00
—
3.4e+00
1.8e+00
1.1e+00
cases:50.61%
controls:33.21%
cases:34.55%
controls:11.99%
cases:36.59%
controls:1.89%
—
—
cases:37.25%
controls:1.91%
cases:44.18%
controls:11.54%
cases:57.14%
controls:30.70%
249
1631
243
3280
170
589
322
4322
180
93
312
4818
—
133
94
224
4815
129
557
163
4268
144
1265
108
2856
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
1.5e+00
2.3e+00
4.1e+00
1.0e+50
—
2.3e+00
1.6e+00
cases:5.28%
controls:1.18%
cases:4.47%
controls:0.49%
cases:5.89%
controls:0.10%
cases:2.64%
controls:0.00%
—
—
cases:5.82%
controls:0.62%
cases:7.94%
controls:1.72%
26
58
466
4853
22
24
470
4887
29
5
463
4906
13
0
479
4911
—
17
30
275
4795
20
71
232
4050
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
L04AA06 [21603896]
2.9e+00
3.0e+00
—
—
—
2.6e+00
3.1e+00
cases:2.64%
controls:0.14%
cases:2.44%
controls:0.12%
—
—
—
—
—
—
cases:1.71%
controls:0.12%
cases:3.17%
controls:0.15%
13
7
479
4904
12
6
480
4905
—
—
—
5
6
287
4819
8
6
244
4115
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
1.1e+00
1.5e+00
3.2e+00
—
3.1e+00
1.7e+00
1.0e+00
cases:11.18%
controls:4.19%
cases:11.38%
controls:2.77%
cases:10.98%
controls:0.51%
—
—
cases:13.73%
controls:0.69%
cases:14.73%
controls:3.11%
cases:16.27%
controls:6.48%
55
206
437
4705
56
136
436
4775
54
25
438
4886
—
49
34
308
4875
43
150
249
4675
41
267
211
3854
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
1.1e+00
1.8e+00
2.1e+00
—
3.1e+00
2.2e+00
1.3e+00
cases:22.36%
controls:8.84%
cases:19.92%
controls:4.05%
cases:6.71%
controls:0.83%
—
—
cases:12.61%
controls:0.65%
cases:27.40%
controls:4.19%
cases:30.95%
controls:11.31%
110
434
382
4477
98
199
394
4712
33
41
459
4870
—
45
32
312
4877
80
202
212
4623
78
466
174
3655
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
2.4e-01
7.3e-01
2.6e+00
4.8e+00
2.6e+00
7.5e-01
3.7e-01
cases:24.39%
controls:20.20%
cases:23.58%
controls:12.89%
cases:23.78%
controls:2.34%
cases:21.95%
controls:0.22%
cases:27.17%
controls:2.63%
cases:26.03%
controls:14.26%
cases:38.89%
controls:30.43%
120
992
372
3919
116
633
376
4278
117
115
375
4796
108
11
384
4900
97
129
260
4780
76
688
216
4137
98
1254
154
2867
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
26498-6 [3017181]
1.4e+00
1.0e+00
3.6e+00
—
3.2e+00
1.8e+00
1.5e+00
cases:3.05%
controls:0.75%
cases:1.83%
controls:0.65%
cases:3.66%
controls:0.10%
—
—
cases:3.92%
controls:0.16%
cases:3.08%
controls:0.54%
cases:5.16%
controls:1.24%
15
37
477
4874
9
32
483
4879
18
5
474
4906
—
14
8
343
4901
9
26
283
4799
13
51
239
4070
General Surgery
2 [38004447]
2 [38004447]
3.9e-01
8.6e-01
2.6e+00
4.0e+00
2.2e+00
7.8e-01
6.5e-01
cases:27.85%
controls:20.69%
cases:14.63%
controls:6.76%
cases:12.40%
controls:1.06%
cases:6.50%
controls:0.12%
cases:7.00%
controls:0.86%
cases:13.01%
controls:6.40%
cases:29.37%
controls:17.86%
137
1016
355
3895
72
332
420
4579
61
52
431
4859
32
6
460
4905
25
42
332
4867
38
309
254
4516
74
736
178
3385
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
1.1e+00
1.8e+00
2.1e+00
—
3.1e+00
2.2e+00
1.2e+00
cases:22.15%
controls:8.84%
cases:19.92%
controls:4.03%
cases:6.71%
controls:0.83%
—
—
cases:12.32%
controls:0.65%
cases:27.40%
controls:4.17%
cases:30.56%
controls:11.31%
109
434
383
4477
98
198
394
4713
33
41
459
4870
—
44
32
313
4877
80
201
212
4624
77
466
175
3655
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
1.4e+00
2.0e+00
—
1.0e+50
4.6e+00
2.0e+00
1.4e+00
cases:7.11%
controls:1.85%
cases:6.10%
controls:0.88%
—
—
cases:2.03%
controls:0.00%
cases:12.04%
controls:0.14%
cases:6.51%
controls:0.93%
cases:9.52%
controls:2.60%
35
91
457
4820
30
43
462
4868
—
10
0
482
4911
43
7
314
4902
19
45
273
4780
24
107
228
4014
Outpatient Hospital
22 [8756]
22 [8756]
6.3e-01
1.2e+00
3.6e+00
—
3.2e+00
1.7e+00
9.5e-01
cases:38.21%
controls:24.74%
cases:22.15%
controls:7.68%
cases:24.59%
controls:0.90%
—
—
cases:17.65%
controls:0.84%
cases:29.11%
controls:7.15%
cases:43.25%
controls:22.74%
188
1215
304
3696
109
377
383
4534
121
44
371
4867
—
63
41
294
4868
85
345
207
4480
109
937
143
3184
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
6.2e-01
1.0e+00
3.6e+00
—
3.9e+00
1.2e+00
7.2e-01
cases:8.33%
controls:4.68%
cases:4.88%
controls:1.77%
cases:5.08%
controls:0.14%
—
—
cases:5.88%
controls:0.12%
cases:6.16%
controls:1.95%
cases:12.30%
controls:6.38%
41
230
451
4681
24
87
468
4824
25
7
467
4904
—
21
6
336
4903
18
94
274
4731
31
263
221
3858
Dyspnoea
R06.0 [45558449]
R06.0 [45558449]
1.0e+00
1.4e+00
3.6e+00
1.0e+50
2.2e+00
1.9e+00
1.0e+00
cases:7.72%
controls:2.97%
cases:4.27%
controls:1.06%
cases:3.46%
controls:0.10%
cases:1.83%
controls:0.00%
cases:1.68%
controls:0.18%
cases:6.85%
controls:1.12%
cases:10.32%
controls:4.08%
38
146
454
4765
21
52
471
4859
17
5
475
4906
9
0
483
4911
6
9
351
4900
20
54
272
4771
26
168
226
3953
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
8.2e-01
1.3e+00
3.4e+00
1.0e+50
3.4e+00
1.2e+00
8.2e-01
cases:13.41%
controls:6.41%
cases:10.16%
controls:3.03%
cases:10.77%
controls:0.41%
cases:9.15%
controls:0.00%
cases:12.61%
controls:0.49%
cases:11.99%
controls:3.85%
cases:19.44%
controls:9.63%
66
315
426
4596
50
149
442
4762
53
20
439
4891
45
0
447
4911
45
24
312
4885
35
186
257
4639
49
397
203
3724
Internal Medicine
11 [38004456]
11 [38004456]
8.3e-01
1.4e+00
3.3e+00
—
2.6e+00
1.6e+00
1.1e+00
cases:41.67%
controls:23.68%
cases:30.89%
controls:10.22%
cases:26.42%
controls:1.32%
—
—
cases:18.77%
controls:1.63%
cases:33.90%
controls:9.49%
cases:48.02%
controls:22.81%
205
1163
287
3748
152
502
340
4409
130
65
362
4846
—
67
80
290
4829
99
458
193
4367
121
940
131
3181
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
8.2e-01
1.3e+00
3.0e+00
—
3.3e+00
1.3e+00
8.4e-01
cases:13.21%
controls:6.27%
cases:11.59%
controls:3.54%
cases:7.72%
controls:0.43%
—
—
cases:10.92%
controls:0.45%
cases:11.99%
controls:3.48%
cases:20.24%
controls:9.90%
65
308
427
4603
57
174
435
4737
38
21
454
4890
—
39
22
318
4887
35
168
257
4657
51
408
201
3713
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
1.2e+00
1.7e+00
3.0e+00
1.0e+50
2.6e+00
1.9e+00
9.0e-01
cases:7.72%
controls:2.46%
cases:3.86%
controls:0.75%
cases:2.44%
controls:0.12%
cases:2.85%
controls:0.00%
cases:1.68%
controls:0.12%
cases:5.82%
controls:0.89%
cases:6.75%
controls:2.86%
38
121
454
4790
19
37
473
4874
12
6
480
4905
14
0
478
4911
6
6
351
4903
17
43
275
4782
17
118
235
4003
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
1.6e+00
2.4e+00
—
—
2.6e+00
2.3e+00
1.5e+00
cases:2.85%
controls:0.59%
cases:3.46%
controls:0.33%
—
—
—
—
cases:1.68%
controls:0.12%
cases:3.08%
controls:0.33%
cases:3.57%
controls:0.80%
14
29
478
4882
17
16
475
4895
—
—
6
6
351
4903
9
16
283
4809
9
33
243
4088
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
8.6e-01
1.3e+00
2.8e+00
—
3.0e+00
1.4e+00
9.7e-01
cases:14.02%
controls:6.48%
cases:13.41%
controls:3.97%
cases:11.79%
controls:0.77%
—
—
cases:15.41%
controls:0.94%
cases:16.10%
controls:4.39%
cases:21.83%
controls:9.56%
69
318
423
4593
66
195
426
4716
58
38
434
4873
—
55
46
302
4863
47
212
245
4613
55
394
197
3727
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
8.5e-01
1.3e+00
2.8e+00
—
2.9e+00
1.4e+00
9.9e-01
cases:13.82%
controls:6.43%
cases:13.41%
controls:3.99%
cases:11.79%
controls:0.77%
—
—
cases:14.85%
controls:0.94%
cases:15.75%
controls:4.29%
cases:21.83%
controls:9.42%
68
316
424
4595
66
196
426
4715
58
38
434
4873
—
53
46
304
4863
46
207
246
4618
55
388
197
3733
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
1.0e+00
9.5e-01
3.2e+00
1.0e+50
2.9e+00
1.4e+00
8.5e-01
cases:6.50%
controls:2.48%
cases:3.86%
controls:1.53%
cases:4.27%
controls:0.18%
cases:1.02%
controls:0.00%
cases:5.88%
controls:0.35%
cases:7.19%
controls:1.84%
cases:8.73%
controls:3.93%
32
122
460
4789
19
75
473
4836
21
9
471
4902
5
0
487
4911
21
17
336
4892
21
89
271
4736
22
162
230
3959
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
7.1e-01
1.4e+00
3.3e+00
1.0e+50
3.2e+00
1.1e+00
5.9e-01
cases:13.62%
controls:7.17%
cases:11.99%
controls:3.38%
cases:11.59%
controls:0.47%
cases:7.93%
controls:0.00%
cases:12.32%
controls:0.55%
cases:11.99%
controls:4.46%
cases:17.86%
controls:10.73%
67
352
425
4559
59
166
433
4745
57
23
435
4888
39
0
453
4911
44
27
313
4882
35
215
257
4610
45
442
207
3679
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
8.5e-01
1.3e+00
2.8e+00
—
2.9e+00
1.4e+00
9.5e-01
cases:13.82%
controls:6.43%
cases:13.41%
controls:3.97%
cases:11.59%
controls:0.77%
—
—
cases:14.85%
controls:0.94%
cases:15.75%
controls:4.33%
cases:21.43%
controls:9.56%
68
316
424
4595
66
195
426
4716
57
38
435
4873
—
53
46
304
4863
46
209
246
4616
54
394
198
3727
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
7.9e-01
1.6e+00
3.9e+00
—
2.9e+00
1.1e+00
5.7e-01
cases:7.32%
controls:3.46%
cases:8.54%
controls:1.87%
cases:9.76%
controls:0.22%
—
—
cases:4.20%
controls:0.24%
cases:6.85%
controls:2.45%
cases:11.90%
controls:7.09%
36
170
456
4741
42
92
450
4819
48
11
444
4900
—
15
12
342
4897
20
118
272
4707
30
292
222
3829
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
8.2e-01
1.3e+00
2.8e+00
—
3.0e+00
1.4e+00
8.7e-01
cases:13.82%
controls:6.60%
cases:13.62%
controls:4.15%
cases:11.79%
controls:0.79%
—
—
cases:15.41%
controls:0.94%
cases:16.44%
controls:4.44%
cases:21.03%
controls:10.07%
68
324
424
4587
67
204
425
4707
58
39
434
4872
—
55
46
302
4863
48
214
244
4611
53
415
199
3706
ciclosporin; oral, parenteral
L04AD01 [21603924]
L04AD01 [21603924]
2.1e+00
2.6e+00
—
—
—
2.6e+00
2.8e+00
cases:2.03%
controls:0.24%
cases:1.63%
controls:0.12%
—
—
—
—
—
—
cases:1.71%
controls:0.12%
cases:1.98%
controls:0.12%
10
12
482
4899
8
6
484
4905
—
—
—
5
6
287
4819
5
5
247
4116
Emergency Room Visit
ER [9203]
ER [9203]
6.6e-01
1.4e+00
3.5e+00
—
2.1e+00
1.3e+00
1.1e+00
cases:47.36%
controls:31.83%
cases:36.79%
controls:12.14%
cases:36.59%
controls:1.71%
—
—
cases:13.45%
controls:1.79%
cases:32.19%
controls:11.38%
cases:61.51%
controls:33.88%
233
1563
259
3348
181
596
311
4315
180
84
312
4827
—
48
88
309
4821
94
549
198
4276
155
1396
97
2725
Bacterial pneumonia, unspecified
J15.9 [45557621]
J15.9 [45557621]
1.8e+00
2.7e+00
—
1.0e+50
—
3.9e+00
1.6e+00
cases:4.88%
controls:0.81%
cases:3.05%
controls:0.20%
—
—
cases:9.76%
controls:0.00%
—
—
cases:9.93%
controls:0.23%
cases:6.35%
controls:1.29%
24
40
468
4871
15
10
477
4901
—
48
0
444
4911
—
29
11
263
4814
16
53
236
4068
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
7.8e-01
1.4e+00
2.7e+00
—
2.9e+00
1.4e+00
8.9e-01
cases:13.01%
controls:6.39%
cases:13.62%
controls:3.87%
cases:10.57%
controls:0.77%
—
—
cases:14.29%
controls:0.92%
cases:15.75%
controls:4.33%
cases:20.63%
controls:9.63%
64
314
428
4597
67
190
425
4721
52
38
440
4873
—
51
45
306
4864
46
209
246
4616
52
397
200
3724
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
33959-8 [3046279]
2.1e+00
2.9e+00
1.0e+50
—
1.0e+50
3.0e+00
2.1e+00
cases:2.24%
controls:0.29%
cases:2.44%
controls:0.14%
cases:3.66%
controls:0.00%
—
—
cases:7.28%
controls:0.00%
cases:2.74%
controls:0.15%
cases:5.95%
controls:0.75%
11
14
481
4897
12
7
480
4904
18
0
474
4911
—
26
0
331
4909
8
7
284
4818
15
31
237
4090
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
6.9e-01
1.2e+00
3.0e+00
—
3.1e+00
1.1e+00
7.8e-01
cases:14.43%
controls:7.82%
cases:13.21%
controls:4.32%
cases:11.99%
controls:0.69%
—
—
cases:15.69%
controls:0.79%
cases:12.67%
controls:4.39%
cases:22.22%
controls:11.55%
71
384
421
4527
65
212
427
4699
59
34
433
4877
—
56
39
301
4870
37
212
255
4613
56
476
196
3645
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
5.2e-01
1.2e+00
2.8e+00
1.0e+50
2.8e+00
1.9e+00
1.2e+00
cases:3.46%
controls:2.08%
cases:2.64%
controls:0.83%
cases:2.03%
controls:0.12%
cases:4.47%
controls:0.00%
cases:3.64%
controls:0.22%
cases:4.79%
controls:0.77%
cases:7.14%
controls:2.16%
17
102
475
4809
13
41
479
4870
10
6
482
4905
22
0
470
4911
13
11
344
4898
14
37
278
4788
18
89
234
4032
Heart failure, unspecified
I50.9 [45576879]
I50.9 [45576879]
1.0e+00
1.5e+00
3.0e+00
1.0e+50
2.9e+00
1.5e+00
8.4e-01
cases:4.67%
controls:1.75%
cases:4.27%
controls:1.02%
cases:4.88%
controls:0.26%
cases:5.08%
controls:0.00%
cases:3.36%
controls:0.18%
cases:5.48%
controls:1.26%
cases:7.14%
controls:3.23%
23
86
469
4825
21
50
471
4861
24
13
468
4898
25
0
467
4911
12
9
345
4900
16
61
276
4764
18
133
234
3988
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
5.0e-01
1.2e+00
3.4e+00
1.0e+50
3.7e+00
1.6e+00
6.6e-01
cases:5.08%
controls:3.14%
cases:3.86%
controls:1.20%
cases:4.88%
controls:0.16%
cases:3.66%
controls:0.00%
cases:6.16%
controls:0.16%
cases:6.16%
controls:1.37%
cases:7.14%
controls:3.83%
25
154
467
4757
19
59
473
4852
24
8
468
4903
18
0
474
4911
22
8
335
4901
18
66
274
4759
18
158
234
3963
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
8.1e-01
1.3e+00
2.6e+00
—
2.9e+00
1.4e+00
9.1e-01
cases:14.23%
controls:6.86%
cases:13.62%
controls:4.28%
cases:10.57%
controls:0.86%
—
—
cases:15.69%
controls:1.04%
cases:16.44%
controls:4.77%
cases:23.02%
controls:10.70%
70
337
422
4574
67
210
425
4701
52
42
440
4869
—
56
51
301
4858
48
230
244
4595
58
441
194
3680
Flexible bronchoscopy
UGC12 [2001303610]
UGC12 [2001303610]
1.7e+00
3.4e+00
—
1.0e+50
—
3.0e+00
1.8e+00
cases:3.46%
controls:0.67%
cases:5.08%
controls:0.18%
—
—
cases:4.07%
controls:0.00%
—
—
cases:2.74%
controls:0.15%
cases:5.95%
controls:1.02%
17
33
475
4878
25
9
467
4902
—
20
0
472
4911
—
8
7
284
4818
15
42
237
4079
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
5.3e-01
9.1e-01
3.1e+00
—
3.7e+00
1.3e+00
8.1e-01
cases:7.32%
controls:4.44%
cases:4.47%
controls:1.85%
cases:6.71%
controls:0.33%
—
—
cases:7.00%
controls:0.18%
cases:4.79%
controls:1.37%
cases:11.11%
controls:5.29%
36
218
456
4693
22
91
470
4820
33
16
459
4895
—
25
9
332
4900
14
66
278
4759
28
218
224
3903
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
7.5e-01
1.2e+00
2.7e+00
—
3.8e+00
1.4e+00
5.7e-01
cases:9.15%
controls:4.56%
cases:6.30%
controls:2.04%
cases:3.66%
controls:0.26%
—
—
cases:8.12%
controls:0.20%
cases:8.22%
controls:2.07%
cases:12.70%
controls:7.57%
45
224
447
4687
31
100
461
4811
18
13
474
4898
—
29
10
328
4899
24
100
268
4725
32
312
220
3809
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
7.9e-01
1.2e+00
2.6e+00
—
2.9e+00
1.3e+00
9.2e-01
cases:13.41%
controls:6.58%
cases:13.21%
controls:4.22%
cases:9.96%
controls:0.79%
—
—
cases:15.13%
controls:1.02%
cases:15.41%
controls:4.54%
cases:22.22%
controls:10.24%
66
323
426
4588
65
207
427
4704
49
39
443
4872
—
54
50
303
4859
45
219
247
4606
56
422
196
3699
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
7.8e-01
1.2e+00
2.6e+00
—
2.9e+00
1.4e+00
9.2e-01
cases:13.41%
controls:6.64%
cases:13.21%
controls:4.24%
cases:9.96%
controls:0.79%
—
—
cases:15.13%
controls:1.02%
cases:15.41%
controls:4.50%
cases:22.22%
controls:10.19%
66
326
426
4585
65
208
427
4703
49
39
443
4872
—
54
50
303
4859
45
217
247
4608
56
420
196
3701
Inpatient Visit
IP [9201]
IP [9201]
8.2e-01
1.4e+00
2.9e+00
1.0e+50
3.6e+00
1.0e+00
4.6e-01
cases:13.21%
controls:6.29%
cases:8.54%
controls:2.32%
cases:4.47%
controls:0.24%
cases:4.88%
controls:0.00%
cases:3.64%
controls:0.10%
cases:6.16%
controls:2.32%
cases:9.92%
controls:6.48%
65
309
427
4602
42
114
450
4797
22
12
470
4899
24
0
468
4911
13
5
344
4904
18
112
274
4713
25
267
227
3854
Infectious Disease
44 [38004484]
44 [38004484]
8.8e-01
1.8e+00
—
1.0e+50
3.4e+00
3.1e+00
1.5e+00
cases:2.24%
controls:0.94%
cases:2.64%
controls:0.45%
—
—
cases:4.47%
controls:0.00%
cases:4.20%
controls:0.14%
cases:7.53%
controls:0.37%
cases:7.54%
controls:1.87%
11
46
481
4865
13
22
479
4889
—
22
0
470
4911
15
7
342
4902
22
18
270
4807
19
77
233
4044
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
3.9e-01
1.2e+00
3.7e+00
—
3.1e+00
1.1e+00
6.4e-01
cases:12.80%
controls:9.04%
cases:12.40%
controls:4.19%
cases:14.23%
controls:0.43%
—
—
cases:10.36%
controls:0.51%
cases:13.70%
controls:4.83%
cases:23.02%
controls:13.64%
63
444
429
4467
61
206
431
4705
70
21
422
4890
—
37
25
320
4884
40
233
252
4592
58
562
194
3559
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.6e-01
4.3e-01
2.2e+00
4.7e+00
2.4e+00
4.3e-01
1.3e-01
cases:26.83%
controls:23.80%
cases:26.63%
controls:19.10%
cases:21.95%
controls:3.05%
cases:19.92%
controls:0.22%
cases:26.05%
controls:3.24%
cases:28.08%
controls:20.31%
cases:40.08%
controls:37.10%
132
1169
360
3742
131
938
361
3973
108
150
384
4761
98
11
394
4900
93
159
264
4750
82
980
210
3845
101
1529
151
2592
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
1.3e+00
2.1e+00
—
—
—
3.2e+00
3.0e+00
cases:4.47%
controls:1.20%
cases:3.25%
controls:0.41%
—
—
—
—
—
—
cases:7.53%
controls:0.33%
cases:9.52%
controls:0.51%
22
59
470
4852
16
20
476
4891
—
—
—
22
16
270
4809
24
21
228
4100
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
1.3e+00
2.1e+00
—
—
—
3.2e+00
3.0e+00
cases:4.47%
controls:1.20%
cases:3.25%
controls:0.41%
—
—
—
—
—
—
cases:7.53%
controls:0.33%
cases:9.52%
controls:0.51%
22
59
470
4852
16
20
476
4891
—
—
—
22
16
270
4809
24
21
228
4100
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
1.3e+00
2.1e+00
—
—
—
3.2e+00
3.0e+00
cases:4.47%
controls:1.20%
cases:3.25%
controls:0.41%
—
—
—
—
—
—
cases:7.53%
controls:0.33%
cases:9.52%
controls:0.51%
22
59
470
4852
16
20
476
4891
—
—
—
22
16
270
4809
24
21
228
4100
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
1.3e+00
2.1e+00
—
—
—
3.2e+00
3.0e+00
cases:4.47%
controls:1.20%
cases:3.25%
controls:0.41%
—
—
—
—
—
—
cases:7.53%
controls:0.33%
cases:9.52%
controls:0.51%
22
59
470
4852
16
20
476
4891
—
—
—
22
16
270
4809
24
21
228
4100
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
1.3e+00
2.1e+00
—
—
—
3.2e+00
3.0e+00
cases:4.47%
controls:1.20%
cases:3.25%
controls:0.41%
—
—
—
—
—
—
cases:7.53%
controls:0.33%
cases:9.52%
controls:0.51%
22
59
470
4852
16
20
476
4891
—
—
—
22
16
270
4809
24
21
228
4100
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
7.3e-01
1.2e+00
2.6e+00
—
2.9e+00
1.3e+00
8.8e-01
cases:13.41%
controls:6.92%
cases:13.41%
controls:4.36%
cases:10.37%
controls:0.83%
—
—
cases:15.13%
controls:1.02%
cases:15.41%
controls:4.60%
cases:22.62%
controls:10.77%
66
340
426
4571
66
214
426
4697
51
41
441
4870
—
54
50
303
4859
45
222
247
4603
57
444
195
3677
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
4.9e-01
1.2e+00
3.0e+00
1.0e+50
3.1e+00
1.4e+00
9.4e-01
cases:6.30%
controls:3.97%
cases:4.88%
controls:1.55%
cases:4.47%
controls:0.22%
cases:6.91%
controls:0.00%
cases:6.16%
controls:0.31%
cases:5.14%
controls:1.31%
cases:10.32%
controls:4.32%
31
195
461
4716
24
76
468
4835
22
11
470
4900
34
0
458
4911
22
15
335
4894
15
63
277
4762
26
178
226
3943
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
1.3e+00
2.1e+00
—
—
—
3.1e+00
3.0e+00
cases:5.08%
controls:1.43%
cases:3.66%
controls:0.45%
—
—
—
—
—
—
cases:8.22%
controls:0.39%
cases:12.30%
controls:0.68%
25
70
467
4841
18
22
474
4889
—
—
—
24
19
268
4806
31
28
221
4093
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
1.3e+00
2.1e+00
—
—
—
3.1e+00
3.0e+00
cases:5.08%
controls:1.43%
cases:3.66%
controls:0.45%
—
—
—
—
—
—
cases:8.22%
controls:0.39%
cases:12.30%
controls:0.68%
25
70
467
4841
18
22
474
4889
—
—
—
24
19
268
4806
31
28
221
4093
FEV1
20150-9 [3024653]
20150-9 [3024653]
1.3e+00
2.1e+00
—
—
—
3.1e+00
3.0e+00
cases:5.08%
controls:1.43%
cases:3.66%
controls:0.45%
—
—
—
—
—
—
cases:8.22%
controls:0.39%
cases:12.30%
controls:0.68%
25
70
467
4841
18
22
474
4889
—
—
—
24
19
268
4806
31
28
221
4093
Rheumatology
66 [38004491]
66 [38004491]
1.4e+00
2.1e+00
2.8e+00
—
1.2e+00
1.9e+00
1.3e+00
cases:7.32%
controls:1.93%
cases:7.52%
controls:0.98%
cases:1.63%
controls:0.10%
—
—
cases:1.68%
controls:0.49%
cases:7.53%
controls:1.16%
cases:8.33%
controls:2.35%
36
95
456
4816
37
48
455
4863
8
5
484
4906
—
6
24
351
4885
22
56
270
4769
21
97
231
4024
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
33762-6 [3029187]
6.2e-01
1.3e+00
3.6e+00
—
3.4e+00
1.1e+00
3.4e-01
cases:6.71%
controls:3.73%
cases:7.52%
controls:2.14%
cases:6.10%
controls:0.18%
—
—
cases:8.12%
controls:0.29%
cases:6.85%
controls:2.36%
cases:10.32%
controls:7.55%
33
183
459
4728
37
105
455
4806
30
9
462
4902
—
29
14
328
4895
20
114
272
4711
26
311
226
3810
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
5.2e-01
1.1e+00
2.7e+00
1.0e+50
2.6e+00
1.8e+00
1.2e+00
cases:9.35%
controls:5.80%
cases:4.67%
controls:1.63%
cases:2.64%
controls:0.18%
cases:2.24%
controls:0.00%
cases:1.40%
controls:0.10%
cases:7.19%
controls:1.33%
cases:15.08%
controls:4.95%
46
285
446
4626
23
80
469
4831
13
9
479
4902
11
0
481
4911
5
5
352
4904
21
64
271
4761
38
204
214
3917
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.5e-01
4.0e-01
2.2e+00
4.5e+00
2.3e+00
4.1e-01
1.1e-01
cases:26.83%
controls:24.01%
cases:26.63%
controls:19.51%
cases:21.75%
controls:3.12%
cases:19.92%
controls:0.26%
cases:25.77%
controls:3.42%
cases:28.08%
controls:20.62%
cases:40.08%
controls:37.49%
132
1179
360
3732
131
958
361
3953
107
153
385
4758
98
13
394
4898
92
168
265
4741
82
995
210
3830
101
1545
151
2576
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
8.5e-01
1.3e+00
2.6e+00
—
2.6e+00
1.2e+00
8.2e-01
cases:9.76%
controls:4.40%
cases:7.11%
controls:2.04%
cases:4.07%
controls:0.31%
—
—
cases:4.76%
controls:0.37%
cases:7.88%
controls:2.59%
cases:12.70%
controls:6.02%
48
216
444
4695
35
100
457
4811
20
15
472
4896
—
17
18
340
4891
23
125
269
4700
32
248
220
3873
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
5.9e-02
4.7e-01
2.1e+00
4.7e+00
2.1e+00
3.9e-01
1.7e-01
cases:23.98%
controls:22.93%
cases:22.97%
controls:15.76%
cases:17.89%
controls:2.61%
cases:15.65%
controls:0.16%
cases:20.45%
controls:3.16%
cases:22.60%
controls:16.54%
cases:36.51%
controls:32.61%
118
1126
374
3785
113
774
379
4137
88
128
404
4783
77
8
415
4903
73
155
284
4754
66
798
226
4027
92
1344
160
2777
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
3.7e-01
9.8e-01
3.2e+00
—
3.9e+00
1.2e+00
4.7e-01
cases:9.35%
controls:6.68%
cases:6.50%
controls:2.55%
cases:7.93%
controls:0.35%
—
—
cases:8.40%
controls:0.18%
cases:7.53%
controls:2.30%
cases:12.30%
controls:8.08%
46
328
446
4583
32
125
460
4786
39
17
453
4894
—
30
9
327
4900
22
111
270
4714
31
333
221
3788
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
1.6e+00
1.9e+00
—
—
3.0e+00
2.7e+00
4.9e-01
cases:6.10%
controls:1.26%
cases:3.46%
controls:0.51%
—
—
—
—
cases:2.52%
controls:0.12%
cases:4.11%
controls:0.29%
cases:2.78%
controls:1.72%
30
62
462
4849
17
25
475
4886
—
—
9
6
348
4903
12
14
280
4811
7
71
245
4050
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
8.0e-01
8.9e-01
2.9e+00
—
2.5e+00
1.5e+00
7.7e-01
cases:7.32%
controls:3.44%
cases:3.86%
controls:1.63%
cases:2.44%
controls:0.14%
—
—
cases:1.40%
controls:0.12%
cases:7.88%
controls:1.87%
cases:11.11%
controls:5.46%
36
169
456
4742
19
80
473
4831
12
7
480
4904
—
5
6
352
4903
23
90
269
4735
28
225
224
3896
fluoxetine; oral
N06AB03 [21604711]
N06AB03 [21604711]
1.3e+00
1.7e+00
2.3e+00
—
—
2.0e+00
1.7e+00
cases:4.27%
controls:1.20%
cases:3.05%
controls:0.55%
cases:1.42%
controls:0.14%
—
—
—
—
cases:4.45%
controls:0.60%
cases:4.76%
controls:0.90%
21
59
471
4852
15
27
477
4884
7
7
485
4904
—
—
13
29
279
4796
12
37
240
4084
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
3.4e-01
1.1e+00
2.5e+00
1.0e+50
2.7e+00
1.4e+00
1.2e+00
cases:6.30%
controls:4.58%
cases:4.67%
controls:1.65%
cases:3.66%
controls:0.31%
cases:4.07%
controls:0.00%
cases:3.36%
controls:0.22%
cases:6.51%
controls:1.70%
cases:11.90%
controls:3.88%
31
225
461
4686
23
81
469
4830
18
15
474
4896
20
0
472
4911
12
11
345
4898
19
82
273
4743
30
160
222
3961
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
2000-8 [3015377]
5.4e-01
9.1e-01
2.9e+00
—
3.0e+00
1.2e+00
8.6e-01
cases:6.50%
controls:3.89%
cases:5.28%
controls:2.20%
cases:2.85%
controls:0.16%
—
—
cases:3.92%
controls:0.20%
cases:5.82%
controls:1.76%
cases:13.89%
controls:6.38%
32
191
460
4720
26
108
466
4803
14
8
478
4903
—
14
10
343
4899
17
85
275
4740
35
263
217
3858
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
1.9e-01
7.8e-01
3.6e+00
1.0e+50
2.6e+00
1.5e+00
1.1e+00
cases:7.32%
controls:6.11%
cases:3.05%
controls:1.43%
cases:3.66%
controls:0.10%
cases:2.03%
controls:0.00%
cases:1.68%
controls:0.12%
cases:5.14%
controls:1.22%
cases:12.30%
controls:4.37%
36
300
456
4611
15
70
477
4841
18
5
474
4906
10
0
482
4911
6
6
351
4903
15
59
277
4766
31
180
221
3941
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
7.1e-01
1.1e+00
2.3e+00
—
2.6e+00
1.2e+00
8.6e-01
cases:15.04%
controls:8.00%
cases:14.43%
controls:5.29%
cases:10.77%
controls:1.16%
—
—
cases:15.41%
controls:1.28%
cases:17.12%
controls:5.87%
cases:24.21%
controls:11.89%
74
393
418
4518
71
260
421
4651
53
57
439
4854
—
55
63
302
4846
50
283
242
4542
61
490
191
3631
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
1.8e+00
2.6e+00
—
1.0e+50
—
3.0e+00
1.5e+00
cases:4.27%
controls:0.73%
cases:5.28%
controls:0.43%
—
—
cases:3.66%
controls:0.00%
—
—
cases:6.51%
controls:0.35%
cases:8.33%
controls:1.99%
21
36
471
4875
26
21
466
4890
—
18
0
474
4911
—
19
17
273
4808
21
82
231
4039
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
4.2e-01
1.3e+00
2.8e+00
1.0e+50
3.2e+00
1.5e+00
6.8e-01
cases:6.10%
controls:4.09%
cases:5.89%
controls:1.61%
cases:4.07%
controls:0.26%
cases:2.03%
controls:0.00%
cases:4.76%
controls:0.20%
cases:6.16%
controls:1.43%
cases:8.73%
controls:4.61%
30
201
462
4710
29
79
463
4832
20
13
472
4898
10
0
482
4911
17
10
340
4899
18
69
274
4756
22
190
230
3931
High resolution CT examination of lungs
GD1DD [2001303632]
GD1DD [2001303632]
2.9e+00
—
1.0e+50
1.0e+50
—
3.5e+00
2.4e+00
cases:2.64%
controls:0.14%
—
—
cases:2.24%
controls:0.00%
cases:3.05%
controls:0.00%
—
—
cases:4.45%
controls:0.15%
cases:4.37%
controls:0.41%
13
7
479
4904
—
11
0
481
4911
15
0
477
4911
—
13
7
279
4818
11
17
241
4104
Outpatient Visit
OP [9202]
OP [9202]
4.6e-01
9.2e-01
9.9e-01
3.0e+00
1.2e+00
1.3e+00
9.4e-01
cases:75.00%
controls:65.53%
cases:67.89%
controls:45.82%
cases:23.58%
controls:10.32%
cases:8.94%
controls:0.49%
cases:25.49%
controls:9.59%
cases:77.05%
controls:46.90%
cases:88.49%
controls:74.98%
369
3218
123
1693
334
2250
158
2661
116
507
376
4404
44
24
448
4887
91
471
266
4438
225
2263
67
2562
223
3090
29
1031
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
4.5e-01
1.3e+00
2.2e+00
—
3.6e+00
1.6e+00
6.6e-01
cases:7.11%
controls:4.66%
cases:4.47%
controls:1.22%
cases:1.63%
controls:0.18%
—
—
cases:4.48%
controls:0.12%
cases:5.82%
controls:1.28%
cases:8.73%
controls:4.73%
35
229
457
4682
22
60
470
4851
8
9
484
4902
—
16
6
341
4903
17
62
275
4763
22
195
230
3926
Hematology
82 [38004501]
82 [38004501]
1.1e+00
1.7e+00
2.4e+00
—
2.1e+00
1.3e+00
9.6e-01
cases:3.66%
controls:1.20%
cases:5.28%
controls:1.00%
cases:3.05%
controls:0.29%
—
—
cases:1.68%
controls:0.20%
cases:4.45%
controls:1.22%
cases:3.97%
controls:1.55%
18
59
474
4852
26
49
466
4862
15
14
477
4897
—
6
10
351
4899
13
59
279
4766
10
64
242
4057
General Practice
1 [38004446]
1 [38004446]
8.5e-01
9.2e-01
2.6e+00
1.0e+50
3.0e+00
1.3e+00
4.0e-01
cases:24.39%
controls:12.14%
cases:12.60%
controls:5.44%
cases:10.57%
controls:0.88%
cases:4.47%
controls:0.00%
cases:13.45%
controls:0.79%
cases:20.55%
controls:6.49%
cases:25.40%
controls:18.51%
120
596
372
4315
62
267
430
4644
52
43
440
4868
22
0
470
4911
48
39
309
4870
60
313
232
4512
64
763
188
3358
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
1.5e-01
4.1e-01
2.0e+00
4.3e+00
2.0e+00
2.0e-01
1.3e-01
cases:19.31%
controls:17.15%
cases:20.93%
controls:14.88%
cases:16.26%
controls:2.63%
cases:12.60%
controls:0.20%
cases:17.09%
controls:2.73%
cases:19.52%
controls:16.52%
cases:29.76%
controls:27.03%
95
842
397
4069
103
731
389
4180
80
129
412
4782
62
10
430
4901
61
134
296
4775
57
797
235
4028
75
1114
177
3007
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
1.6e+00
2.3e+00
1.0e+50
1.0e+50
—
2.9e+00
1.8e+00
cases:3.25%
controls:0.67%
cases:2.85%
controls:0.29%
cases:4.07%
controls:0.00%
cases:4.67%
controls:0.00%
—
—
cases:5.82%
controls:0.33%
cases:5.56%
controls:0.97%
16
33
476
4878
14
14
478
4897
20
0
472
4911
23
0
469
4911
—
17
16
275
4809
14
40
238
4081
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
9.9e-01
1.3e+00
2.3e+00
—
2.3e+00
1.7e+00
8.1e-01
cases:5.69%
controls:2.20%
cases:5.08%
controls:1.51%
cases:2.64%
controls:0.26%
—
—
cases:3.08%
controls:0.31%
cases:7.88%
controls:1.49%
cases:7.14%
controls:3.32%
28
108
464
4803
25
74
467
4837
13
13
479
4898
—
11
15
346
4894
23
72
269
4753
18
137
234
3984
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
4.7e-01
9.2e-01
3.1e+00
—
2.5e+00
1.1e+00
5.8e-01
cases:16.06%
controls:10.67%
cases:13.82%
controls:5.99%
cases:12.40%
controls:0.63%
—
—
cases:9.24%
controls:0.86%
cases:15.41%
controls:5.84%
cases:25.79%
controls:16.36%
79
524
413
4387
68
294
424
4617
61
31
431
4880
—
33
42
324
4867
45
282
247
4543
65
674
187
3447
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
5.6e-01
1.2e+00
2.6e+00
—
1.9e+00
1.4e+00
8.6e-01
cases:11.59%
controls:6.96%
cases:6.10%
controls:1.83%
cases:2.85%
controls:0.22%
—
—
cases:1.68%
controls:0.24%
cases:8.56%
controls:2.18%
cases:16.27%
controls:7.60%
57
342
435
4569
30
90
462
4821
14
11
478
4900
—
6
12
351
4897
25
105
267
4720
41
313
211
3808
Thorax extensive CT-examination
GD1BD [2001303621]
GD1BD [2001303621]
1.2e+00
3.0e+00
—
1.0e+50
—
3.1e+00
2.5e+00
cases:1.22%
controls:0.37%
cases:2.03%
controls:0.10%
—
—
cases:3.66%
controls:0.00%
—
—
cases:2.74%
controls:0.12%
cases:3.57%
controls:0.32%
6
18
486
4893
10
5
482
4906
—
18
0
474
4911
—
8
6
284
4819
9
13
243
4108
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2885-2 [3020630]
1.5e+00
2.3e+00
—
—
3.0e+00
1.7e+00
1.2e+00
cases:4.07%
controls:0.90%
cases:4.07%
controls:0.43%
—
—
—
—
cases:2.52%
controls:0.12%
cases:3.42%
controls:0.64%
cases:4.76%
controls:1.53%
20
44
472
4867
20
21
472
4890
—
—
9
6
348
4903
10
31
282
4794
12
63
240
4058
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
9.6e-02
3.3e-01
2.0e+00
4.5e+00
2.0e+00
2.9e-01
9.0e-02
cases:27.24%
controls:25.37%
cases:27.44%
controls:21.40%
cases:23.17%
controls:3.97%
cases:20.93%
controls:0.29%
cases:26.05%
controls:4.36%
cases:28.42%
controls:22.88%
cases:41.67%
controls:39.50%
134
1246
358
3665
135
1051
357
3860
114
195
378
4716
103
14
389
4897
93
214
264
4695
83
1104
209
3721
105
1628
147
2493
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
1.7e-01
3.5e-01
2.0e+00
4.5e+00
2.0e+00
2.5e-01
1.1e-01
cases:19.11%
controls:16.64%
cases:18.50%
controls:13.81%
cases:15.65%
controls:2.38%
cases:15.45%
controls:0.20%
cases:17.37%
controls:2.79%
cases:18.49%
controls:15.03%
cases:28.17%
controls:26.01%
94
817
398
4094
91
678
401
4233
77
117
415
4794
76
10
416
4901
62
137
295
4772
54
725
238
4100
71
1072
181
3049
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
J01EE01 [21602961]
1.5e+00
2.2e+00
—
—
—
3.1e+00
1.7e+00
cases:2.64%
controls:0.61%
cases:2.44%
controls:0.26%
—
—
—
—
—
—
cases:5.48%
controls:0.27%
cases:3.97%
controls:0.75%
13
30
479
4881
12
13
480
4898
—
—
—
16
13
276
4812
10
31
242
4090
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6968-2 [3009445]
2.6e+00
2.5e+00
—
—
1.0e+50
3.3e+00
1.6e+00
cases:4.07%
controls:0.31%
cases:2.44%
controls:0.20%
—
—
—
—
cases:3.92%
controls:0.00%
cases:2.74%
controls:0.10%
cases:2.78%
controls:0.56%
20
15
472
4896
12
10
480
4901
—
—
14
0
343
4909
8
5
284
4820
7
23
245
4098
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
1.6e-01
4.0e-01
1.9e+00
4.0e+00
2.0e+00
2.8e-01
5.7e-02
cases:26.42%
controls:23.48%
cases:25.00%
controls:18.29%
cases:16.46%
controls:2.83%
cases:8.54%
controls:0.16%
cases:19.61%
controls:3.12%
cases:24.66%
controls:19.77%
cases:38.10%
controls:36.76%
130
1153
362
3758
123
898
369
4013
81
139
411
4772
42
8
450
4903
70
153
287
4756
72
954
220
3871
96
1515
156
2606
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
7.1e-02
3.0e-01
1.9e+00
4.5e+00
1.9e+00
2.0e-01
3.2e-02
cases:28.25%
controls:26.84%
cases:28.66%
controls:22.93%
cases:24.39%
controls:4.48%
cases:22.76%
controls:0.33%
cases:26.89%
controls:4.99%
cases:28.77%
controls:24.81%
cases:42.46%
controls:41.69%
139
1318
353
3593
141
1126
351
3785
120
220
372
4691
112
16
380
4895
96
245
261
4664
84
1197
208
3628
107
1718
145
2403
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
7.5e-02
3.0e-01
1.9e+00
4.5e+00
2.0e+00
2.1e-01
2.3e-02
cases:28.25%
controls:26.76%
cases:28.66%
controls:22.87%
cases:24.39%
controls:4.46%
cases:22.36%
controls:0.33%
cases:26.89%
controls:4.91%
cases:28.77%
controls:24.73%
cases:42.06%
controls:41.49%
139
1314
353
3597
141
1123
351
3788
120
219
372
4692
110
16
382
4895
96
241
261
4668
84
1193
208
3632
106
1710
146
2411
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
7.2e-02
3.1e-01
1.9e+00
4.5e+00
2.0e+00
2.2e-01
1.5e-02
cases:28.25%
controls:26.82%
cases:28.86%
controls:22.93%
cases:24.39%
controls:4.48%
cases:22.56%
controls:0.33%
cases:26.89%
controls:4.95%
cases:29.11%
controls:24.77%
cases:42.06%
controls:41.69%
139
1317
353
3594
142
1126
350
3785
120
220
372
4691
111
16
381
4895
96
243
261
4666
85
1195
207
3630
106
1718
146
2403
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
7.3e-02
3.0e-01
1.9e+00
4.5e+00
2.0e+00
2.0e-01
1.7e-02
cases:28.25%
controls:26.80%
cases:28.66%
controls:22.89%
cases:24.39%
controls:4.48%
cases:22.36%
controls:0.33%
cases:26.89%
controls:4.93%
cases:28.77%
controls:24.77%
cases:42.06%
controls:41.64%
139
1316
353
3595
141
1124
351
3787
120
220
372
4691
110
16
382
4895
96
242
261
4667
84
1195
208
3630
106
1716
146
2405
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
7.5e-02
3.0e-01
1.9e+00
4.5e+00
2.0e+00
1.9e-01
1.9e-02
cases:28.25%
controls:26.76%
cases:28.66%
controls:22.89%
cases:24.39%
controls:4.48%
cases:22.36%
controls:0.33%
cases:26.89%
controls:4.93%
cases:28.42%
controls:24.70%
cases:42.06%
controls:41.59%
139
1314
353
3597
141
1124
351
3787
120
220
372
4691
110
16
382
4895
96
242
261
4667
83
1192
209
3633
106
1714
146
2407
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
7.4e-02
3.0e-01
1.9e+00
4.5e+00
2.0e+00
1.9e-01
1.7e-02
cases:28.25%
controls:26.78%
cases:28.66%
controls:22.91%
cases:24.39%
controls:4.48%
cases:22.36%
controls:0.33%
cases:26.89%
controls:4.93%
cases:28.42%
controls:24.77%
cases:42.06%
controls:41.64%
139
1315
353
3596
141
1125
351
3786
120
220
372
4691
110
16
382
4895
96
242
261
4667
83
1195
209
3630
106
1716
146
2405
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
7.3e-02
3.0e-01
1.9e+00
4.5e+00
2.0e+00
2.1e-01
1.9e-02
cases:28.25%
controls:26.80%
cases:28.66%
controls:22.95%
cases:24.39%
controls:4.48%
cases:22.15%
controls:0.33%
cases:26.89%
controls:4.91%
cases:28.77%
controls:24.70%
cases:42.06%
controls:41.59%
139
1316
353
3595
141
1127
351
3784
120
220
372
4691
109
16
383
4895
96
241
261
4668
84
1192
208
3633
106
1714
146
2407
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
1.2e+00
2.3e+00
—
—
—
3.2e+00
1.6e+00
cases:2.44%
controls:0.73%
cases:3.05%
controls:0.31%
—
—
—
—
—
—
cases:3.77%
controls:0.17%
cases:5.16%
controls:1.04%
12
36
480
4875
15
15
477
4896
—
—
—
11
8
281
4817
13
43
239
4078
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
9.6e-01
1.8e+00
2.8e+00
—
—
1.6e+00
1.1e+00
cases:4.88%
controls:1.93%
cases:3.86%
controls:0.67%
cases:2.03%
controls:0.12%
—
—
—
—
cases:3.42%
controls:0.70%
cases:6.35%
controls:2.21%
24
95
468
4816
19
33
473
4878
10
6
482
4905
—
—
10
34
282
4791
16
91
236
4030
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
7.5e-01
1.1e+00
2.6e+00
—
2.8e+00
1.0e+00
5.9e-01
cases:10.16%
controls:5.07%
cases:7.72%
controls:2.75%
cases:3.86%
controls:0.31%
—
—
cases:4.48%
controls:0.29%
cases:9.93%
controls:3.77%
cases:15.48%
controls:9.22%
50
249
442
4662
38
135
454
4776
19
15
473
4896
—
16
14
341
4895
29
182
263
4643
39
380
213
3741
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
2458-8 [3007164]
8.2e-01
1.8e+00
—
—
2.8e+00
1.7e+00
1.0e+00
cases:4.67%
controls:2.12%
cases:3.86%
controls:0.67%
—
—
—
—
cases:1.68%
controls:0.10%
cases:3.42%
controls:0.62%
cases:7.54%
controls:2.79%
23
104
469
4807
19
33
473
4878
—
—
6
5
351
4904
10
30
282
4795
19
115
233
4006
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
4.9e-01
8.6e-01
2.6e+00
—
2.6e+00
9.1e-01
5.9e-01
cases:20.12%
controls:13.34%
cases:17.68%
controls:8.31%
cases:15.24%
controls:1.28%
—
—
cases:16.81%
controls:1.51%
cases:19.18%
controls:8.70%
cases:30.95%
controls:19.83%
99
655
393
4256
87
408
405
4503
75
63
417
4848
—
60
74
297
4835
56
420
236
4405
78
817
174
3304
Joint ultrasound examination not elsewhere classified
NK4XE [2001308469]
NK4XE [2001308469]
1.5e+00
2.1e+00
—
—
—
2.5e+00
1.9e+00
cases:2.03%
controls:0.45%
cases:1.42%
controls:0.18%
—
—
—
—
—
—
cases:1.71%
controls:0.15%
cases:2.78%
controls:0.44%
10
22
482
4889
7
9
485
4902
—
—
—
5
7
287
4818
7
18
245
4103
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
4.3e-01
8.3e-01
4.0e+00
—
3.1e+00
8.0e-01
3.9e-01
cases:8.33%
controls:5.58%
cases:5.89%
controls:2.67%
cases:9.15%
controls:0.18%
—
—
cases:7.00%
controls:0.35%
cases:6.16%
controls:2.88%
cases:12.70%
controls:8.95%
41
274
451
4637
29
131
463
4780
45
9
447
4902
—
25
17
332
4892
18
139
274
4686
32
369
220
3752
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
4.7e-01
1.0e+00
3.0e+00
—
2.3e+00
1.1e+00
4.8e-01
cases:16.46%
controls:10.95%
cases:14.43%
controls:5.66%
cases:13.21%
controls:0.77%
—
—
cases:8.40%
controls:0.88%
cases:14.73%
controls:5.66%
cases:23.81%
controls:16.19%
81
538
411
4373
71
278
421
4633
65
38
427
4873
—
30
43
327
4866
43
273
249
4552
60
667
192
3454
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
4.6e-01
1.0e+00
2.9e+00
—
3.9e+00
1.0e+00
6.9e-01
cases:5.08%
controls:3.26%
cases:3.86%
controls:1.41%
cases:4.67%
controls:0.26%
—
—
cases:4.76%
controls:0.10%
cases:3.08%
controls:1.16%
cases:7.54%
controls:3.93%
25
160
467
4751
19
69
473
4842
23
13
469
4898
—
17
5
340
4904
9
56
283
4769
19
162
233
3959
Blasts/Leukocytes in Blood
26446-5 [3025159]
26446-5 [3025159]
1.3e+00
9.9e-01
3.6e+00
—
2.9e+00
—
1.3e+00
cases:2.03%
controls:0.55%
cases:1.63%
controls:0.61%
cases:3.46%
controls:0.10%
—
—
cases:3.36%
controls:0.18%
—
—
cases:4.76%
controls:1.31%
10
27
482
4884
8
30
484
4881
17
5
475
4906
—
12
9
345
4900
—
12
54
240
4067
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
8.6e-01
1.2e+00
2.5e+00
1.0e+50
2.3e+00
9.1e-01
9.3e-01
cases:5.89%
controls:2.59%
cases:4.47%
controls:1.34%
cases:2.64%
controls:0.22%
cases:3.05%
controls:0.00%
cases:2.80%
controls:0.29%
cases:3.77%
controls:1.55%
cases:7.94%
controls:3.30%
29
127
463
4784
22
66
470
4845
13
11
479
4900
15
0
477
4911
10
14
347
4895
11
75
281
4750
20
136
232
3985
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
-8.9e-02
2.1e-01
1.7e+00
4.3e+00
1.8e+00
1.9e-01
-2.7e-02
cases:18.50%
controls:19.87%
cases:18.70%
controls:15.72%
cases:15.04%
controls:3.05%
cases:14.02%
controls:0.22%
cases:15.41%
controls:2.91%
cases:19.86%
controls:16.99%
cases:30.56%
controls:31.13%
91
976
401
3935
92
772
400
4139
74
150
418
4761
69
11
423
4900
55
143
302
4766
58
820
234
4005
77
1283
175
2838
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
6.0e-01
1.7e+00
3.0e+00
—
—
2.0e+00
1.1e+00
cases:3.25%
controls:1.81%
cases:3.86%
controls:0.73%
cases:2.85%
controls:0.14%
—
—
—
—
cases:6.16%
controls:0.87%
cases:6.75%
controls:2.38%
16
89
476
4822
19
36
473
4875
14
7
478
4904
—
—
18
42
274
4783
17
98
235
4023
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
3216-9 [3020427]
1.1e+00
2.5e+00
1.0e+50
—
1.0e+50
3.0e+00
2.2e+00
cases:1.42%
controls:0.49%
cases:2.03%
controls:0.16%
cases:2.44%
controls:0.00%
—
—
cases:4.20%
controls:0.00%
cases:2.05%
controls:0.10%
cases:3.97%
controls:0.44%
7
24
485
4887
10
8
482
4903
12
0
480
4911
—
15
0
342
4909
6
5
286
4820
10
18
242
4103
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
1.1e+00
1.7e+00
—
—
2.8e+00
2.2e+00
1.0e+00
cases:5.08%
controls:1.71%
cases:3.25%
controls:0.63%
—
—
—
—
cases:1.96%
controls:0.12%
cases:4.79%
controls:0.58%
cases:4.37%
controls:1.63%
25
84
467
4827
16
31
476
4880
—
—
7
6
350
4903
14
28
278
4797
11
67
241
4054
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
4542-7 [3012336]
1.4e+00
2.2e+00
—
—
—
2.5e+00
1.6e+00
cases:2.64%
controls:0.69%
cases:2.44%
controls:0.26%
—
—
—
—
—
—
cases:3.08%
controls:0.25%
cases:3.97%
controls:0.85%
13
34
479
4877
12
13
480
4898
—
—
—
9
12
283
4813
10
35
242
4086
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 [4010399]
113016006 [4010399]
1.3e+00
2.0e+00
—
—
—
2.7e+00
1.6e+00
cases:4.67%
controls:1.32%
cases:3.46%
controls:0.47%
—
—
—
—
—
—
cases:5.14%
controls:0.35%
cases:7.94%
controls:1.65%
23
65
469
4846
17
23
475
4888
—
—
—
15
17
277
4808
20
68
232
4053
Thorax CT examination
GD1AD [2001303618]
GD1AD [2001303618]
1.4e+00
2.3e+00
1.0e+50
1.0e+50
—
3.3e+00
2.0e+00
cases:1.42%
controls:0.35%
cases:1.22%
controls:0.12%
cases:1.63%
controls:0.00%
cases:5.89%
controls:0.00%
—
—
cases:4.45%
controls:0.17%
cases:3.97%
controls:0.53%
7
17
485
4894
6
6
486
4905
8
0
484
4911
29
0
463
4911
—
13
8
279
4817
10
22
242
4099
furosemide; oral, parenteral
C03CA01 [21601518]
C03CA01 [21601518]
9.6e-01
1.2e+00
9.6e-01
—
1.7e+00
1.6e+00
1.3e+00
cases:16.46%
controls:6.98%
cases:16.26%
controls:5.64%
cases:5.08%
controls:2.02%
—
—
cases:8.96%
controls:1.83%
cases:25.68%
controls:6.30%
cases:28.17%
controls:9.90%
81
343
411
4568
80
277
412
4634
25
99
467
4812
—
32
90
325
4819
75
304
217
4521
71
408
181
3713
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
JN1AE [2001305517]
1.3e+00
2.0e+00
—
1.0e+50
—
2.7e+00
1.7e+00
cases:2.44%
controls:0.65%
cases:1.42%
controls:0.20%
—
—
cases:2.24%
controls:0.00%
—
—
cases:2.74%
controls:0.19%
cases:4.76%
controls:0.95%
12
32
480
4879
7
10
485
4901
—
11
0
481
4911
—
8
9
284
4816
12
39
240
4082
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
4.2e-01
8.7e-01
2.5e+00
—
2.2e+00
1.1e+00
5.3e-01
cases:18.09%
controls:12.62%
cases:14.02%
controls:6.37%
cases:8.13%
controls:0.69%
—
—
cases:7.56%
controls:0.90%
cases:18.15%
controls:7.03%
cases:26.59%
controls:17.59%
89
620
403
4291
69
313
423
4598
40
34
452
4877
—
27
44
330
4865
53
339
239
4486
67
725
185
3396
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
1.2e+00
1.9e+00
—
—
—
2.8e+00
1.7e+00
cases:3.25%
controls:1.02%
cases:3.46%
controls:0.53%
—
—
—
—
—
—
cases:4.45%
controls:0.27%
cases:8.33%
controls:1.63%
16
50
476
4861
17
26
475
4885
—
—
—
13
13
279
4812
21
67
231
4054
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
24351-9 [3004588]
1.7e+00
1.8e+00
—
—
2.6e+00
1.5e+00
6.9e-01
cases:3.66%
controls:0.71%
cases:2.44%
controls:0.43%
—
—
—
—
cases:1.68%
controls:0.12%
cases:2.74%
controls:0.60%
cases:2.38%
controls:1.21%
18
35
474
4876
12
21
480
4890
—
—
6
6
351
4903
8
29
284
4796
6
50
246
4071
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
5128-4 [3001334]
2.2e+00
2.3e+00
—
—
1.0e+50
3.0e+00
1.5e+00
cases:3.25%
controls:0.37%
cases:1.83%
controls:0.18%
—
—
—
—
cases:3.36%
controls:0.00%
cases:2.40%
controls:0.12%
cases:2.38%
controls:0.53%
16
18
476
4893
9
9
483
4902
—
—
12
0
345
4909
7
6
285
4819
6
22
246
4099
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-5.0e-01
7.6e-01
7.2e-01
—
—
3.6e+00
3.7e+00
cases:16.06%
controls:23.91%
cases:15.04%
controls:7.66%
cases:1.63%
controls:0.79%
—
—
—
—
cases:12.33%
controls:0.39%
cases:21.03%
controls:0.68%
79
1174
413
3737
74
376
418
4535
8
39
484
4872
—
—
36
19
256
4806
53
28
199
4093
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
7.0e-01
9.8e-01
2.8e+00
1.0e+50
2.1e+00
8.6e-01
2.2e-01
cases:8.54%
controls:4.42%
cases:6.91%
controls:2.71%
cases:5.69%
controls:0.37%
cases:1.42%
controls:0.00%
cases:3.64%
controls:0.45%
cases:6.51%
controls:2.86%
cases:9.13%
controls:7.43%
42
217
450
4694
34
133
458
4778
28
18
464
4893
7
0
485
4911
13
22
344
4887
19
138
273
4687
23
306
229
3815
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
1.4e+00
2.5e+00
—
1.0e+50
—
2.2e+00
1.3e+00
cases:6.50%
controls:1.63%
cases:7.32%
controls:0.63%
—
—
cases:21.34%
controls:0.00%
—
—
cases:5.82%
controls:0.68%
cases:8.73%
controls:2.50%
32
80
460
4831
36
31
456
4880
—
105
0
387
4911
—
17
33
275
4792
22
103
230
4018
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
7.6e-01
9.8e-01
2.9e+00
1.0e+50
1.9e+00
8.9e-01
3.4e-01
cases:10.57%
controls:5.25%
cases:7.72%
controls:3.05%
cases:6.10%
controls:0.37%
cases:1.22%
controls:0.00%
cases:3.64%
controls:0.55%
cases:6.85%
controls:2.94%
cases:10.71%
controls:7.86%
52
258
440
4653
38
150
454
4761
30
18
462
4893
6
0
486
4911
13
27
344
4882
20
142
272
4683
27
324
225
3797
Emergency Medicine
93 [38004510]
93 [38004510]
4.8e-01
1.0e+00
3.2e+00
—
1.6e+00
1.1e+00
3.7e-01
cases:14.63%
controls:9.55%
cases:14.02%
controls:5.42%
cases:14.23%
controls:0.65%
—
—
cases:3.36%
controls:0.71%
cases:15.07%
controls:5.80%
cases:21.83%
controls:16.14%
72
469
420
4442
69
266
423
4645
70
32
422
4879
—
12
35
345
4874
44
280
248
4545
55
665
197
3456
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
30342-0 [3015171]
2.2e+00
2.3e+00
—
—
—
2.8e+00
—
cases:2.03%
controls:0.22%
cases:1.63%
controls:0.16%
—
—
—
—
—
—
cases:1.71%
controls:0.10%
—
—
10
11
482
4900
8
8
484
4903
—
—
—
5
5
287
4820
—
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
6.1e-01
9.6e-01
2.7e+00
1.0e+50
2.2e+00
8.7e-01
1.7e-01
cases:8.54%
controls:4.85%
cases:7.52%
controls:3.03%
cases:5.89%
controls:0.41%
cases:1.42%
controls:0.00%
cases:3.92%
controls:0.47%
cases:7.19%
controls:3.13%
cases:9.92%
controls:8.49%
42
238
450
4673
37
149
455
4762
29
20
463
4891
7
0
485
4911
14
23
343
4886
21
151
271
4674
25
350
227
3771
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
13956-8 [3014162]
1.7e+00
—
—
—
—
3.5e+00
2.1e+00
cases:2.44%
controls:0.45%
—
—
—
—
—
—
—
—
cases:3.42%
controls:0.10%
cases:4.76%
controls:0.63%
12
22
480
4889
—
—
—
—
10
5
282
4820
12
26
240
4095
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
1.6e+00
1.9e+00
1.0e+50
1.0e+50
—
2.4e+00
1.4e+00
cases:2.85%
controls:0.61%
cases:1.83%
controls:0.29%
cases:4.88%
controls:0.00%
cases:5.89%
controls:0.00%
—
—
cases:4.45%
controls:0.41%
cases:5.56%
controls:1.43%
14
30
478
4881
9
14
483
4897
24
0
468
4911
29
0
463
4911
—
13
20
279
4805
14
59
238
4062
calcium carbonate; oral
A12AA04 [21600863]
A12AA04 [21600863]
2.0e+00
2.3e+00
—
—
—
3.0e+00
2.3e+00
cases:1.42%
controls:0.20%
cases:1.02%
controls:0.10%
—
—
—
—
—
—
cases:2.05%
controls:0.10%
cases:3.17%
controls:0.34%
7
10
485
4901
5
5
487
4906
—
—
—
6
5
286
4820
8
14
244
4107
calcium carbonate
A02AC01 [21600065]
A02AC01 [21600065]
2.0e+00
2.3e+00
—
—
—
3.0e+00
2.3e+00
cases:1.42%
controls:0.20%
cases:1.02%
controls:0.10%
—
—
—
—
—
—
cases:2.05%
controls:0.10%
cases:3.17%
controls:0.34%
7
10
485
4901
5
5
487
4906
—
—
—
6
5
286
4820
8
14
244
4107
Atherosclerotic heart disease
I25.1 [45596196]
I25.1 [45596196]
6.7e-01
8.3e-01
2.5e+00
1.0e+50
2.0e+00
1.1e+00
4.2e-01
cases:9.35%
controls:5.01%
cases:6.50%
controls:2.93%
cases:4.88%
controls:0.41%
cases:10.37%
controls:0.00%
cases:4.20%
controls:0.57%
cases:8.22%
controls:2.78%
cases:11.90%
controls:8.13%
46
246
446
4665
32
144
460
4767
24
20
468
4891
51
0
441
4911
15
28
342
4881
24
134
268
4691
30
335
222
3786
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
1.3e+00
1.9e+00
—
1.0e+50
—
2.4e+00
1.5e+00
cases:4.07%
controls:1.12%
cases:3.46%
controls:0.51%
—
—
cases:7.93%
controls:0.00%
—
—
cases:6.51%
controls:0.60%
cases:9.13%
controls:2.26%
20
55
472
4856
17
25
475
4886
—
39
0
453
4911
—
19
29
273
4796
23
93
229
4028
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
14196-0 [3023520]
7.9e-01
1.7e+00
3.3e+00
—
—
2.2e+00
9.6e-01
cases:2.44%
controls:1.12%
cases:2.85%
controls:0.55%
cases:2.64%
controls:0.10%
—
—
—
—
cases:5.14%
controls:0.58%
cases:4.37%
controls:1.72%
12
55
480
4856
14
27
478
4884
13
5
479
4906
—
—
15
28
277
4797
11
71
241
4050
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
6.9e-01
9.0e-01
3.3e+00
1.0e+50
2.3e+00
9.2e-01
6.1e-01
cases:6.91%
controls:3.60%
cases:4.67%
controls:1.95%
cases:4.67%
controls:0.18%
cases:1.83%
controls:0.00%
cases:3.36%
controls:0.35%
cases:5.14%
controls:2.11%
cases:11.11%
controls:6.36%
34
177
458
4734
23
96
469
4815
23
9
469
4902
9
0
483
4911
12
17
345
4892
15
102
277
4723
28
262
224
3859
Other seropositive rheumatoid arthritis
M05.8 [45538634]
M05.8 [45538634]
1.4e+00
1.7e+00
2.7e+00
—
1.8e+00
1.4e+00
1.4e+00
cases:3.66%
controls:0.96%
cases:3.25%
controls:0.61%
cases:2.03%
controls:0.14%
—
—
cases:1.68%
controls:0.29%
cases:2.74%
controls:0.70%
cases:4.76%
controls:1.19%
18
47
474
4864
16
30
476
4881
10
7
482
4904
—
6
14
351
4895
8
34
284
4791
12
49
240
4072
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
E10.7 [45571655]
1.6e+00
1.8e+00
—
—
—
2.0e+00
1.7e+00
cases:2.44%
controls:0.49%
cases:2.03%
controls:0.35%
—
—
—
—
—
—
cases:2.74%
controls:0.37%
cases:4.37%
controls:0.80%
12
24
480
4887
10
17
482
4894
—
—
—
8
18
284
4807
11
33
241
4088
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
OMOP4822009 [45756830]
1.3e+00
2.3e+00
—
1.0e+50
—
2.1e+00
1.5e+00
cases:4.88%
controls:1.43%
cases:4.27%
controls:0.45%
—
—
cases:2.03%
controls:0.00%
—
—
cases:2.74%
controls:0.35%
cases:5.95%
controls:1.41%
24
70
468
4841
21
22
471
4889
—
10
0
482
4911
—
8
17
284
4808
15
58
237
4063
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
1.3e+00
1.9e+00
—
1.0e+50
—
2.4e+00
1.5e+00
cases:4.07%
controls:1.14%
cases:3.25%
controls:0.51%
—
—
cases:8.13%
controls:0.00%
—
—
cases:6.51%
controls:0.60%
cases:9.13%
controls:2.21%
20
56
472
4855
16
25
476
4886
—
40
0
452
4911
—
19
29
273
4796
23
91
229
4030
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
1.3e+00
1.9e+00
—
1.0e+50
—
2.4e+00
1.5e+00
cases:4.07%
controls:1.14%
cases:3.25%
controls:0.51%
—
—
cases:8.13%
controls:0.00%
—
—
cases:6.51%
controls:0.60%
cases:9.13%
controls:2.21%
20
56
472
4855
16
25
476
4886
—
40
0
452
4911
—
19
29
273
4796
23
91
229
4030
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
1.1e+00
1.3e+00
2.4e+00
—
—
1.2e+00
1.1e+00
cases:10.37%
controls:3.83%
cases:4.47%
controls:1.30%
cases:1.83%
controls:0.16%
—
—
—
—
cases:3.77%
controls:1.12%
cases:11.90%
controls:4.32%
51
188
441
4723
22
64
470
4847
9
8
483
4903
—
—
11
54
281
4771
30
178
222
3943
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
1.6e+00
1.8e+00
2.2e+00
—
1.6e+00
1.4e+00
8.4e-01
cases:5.89%
controls:1.22%
cases:3.86%
controls:0.67%
cases:2.44%
controls:0.26%
—
—
cases:1.96%
controls:0.39%
cases:4.11%
controls:0.99%
cases:7.14%
controls:3.23%
29
60
463
4851
19
33
473
4878
12
13
480
4898
—
7
19
350
4890
12
48
280
4777
18
133
234
3988
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
1.2e+00
1.9e+00
—
1.0e+50
—
2.4e+00
1.5e+00
cases:3.86%
controls:1.14%
cases:3.25%
controls:0.51%
—
—
cases:7.72%
controls:0.00%
—
—
cases:6.16%
controls:0.60%
cases:9.52%
controls:2.33%
19
56
473
4855
16
25
476
4886
—
38
0
454
4911
—
18
29
274
4796
24
96
228
4025
Psychiatry
26 [38004469]
26 [38004469]
9.5e-01
1.1e+00
1.2e+00
-1.0e+50
1.7e+00
1.7e+00
1.5e+00
cases:8.33%
controls:3.38%
cases:4.88%
controls:1.71%
cases:2.24%
controls:0.65%
cases:0.00%
controls:0.10%
cases:3.64%
controls:0.69%
cases:8.90%
controls:1.74%
cases:12.70%
controls:3.11%
41
166
451
4745
24
84
468
4827
11
32
481
4879
0
5
492
4906
13
34
344
4875
26
84
266
4741
32
128
220
3993
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
1.6e-02
1.7e-01
1.4e+00
4.2e+00
1.4e+00
2.6e-02
1.8e-02
cases:29.47%
controls:29.14%
cases:31.10%
controls:27.53%
cases:27.85%
controls:8.49%
cases:25.41%
controls:0.53%
cases:27.73%
controls:8.96%
cases:29.79%
controls:29.24%
cases:46.03%
controls:45.60%
145
1431
347
3480
153
1352
339
3559
137
417
355
4494
125
26
367
4885
99
440
258
4469
87
1411
205
3414
116
1879
136
2242
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
7.7e-01
1.1e+00
2.9e+00
1.0e+50
2.1e+00
9.0e-01
2.7e-01
cases:7.93%
controls:3.83%
cases:6.50%
controls:2.22%
cases:5.08%
controls:0.29%
cases:1.02%
controls:0.00%
cases:2.80%
controls:0.35%
cases:5.14%
controls:2.16%
cases:7.14%
controls:5.53%
39
188
453
4723
32
109
460
4802
25
14
467
4897
5
0
487
4911
10
17
347
4892
15
104
277
4721
18
228
234
3893
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
1.0e+00
1.2e+00
2.5e+00
—
2.0e+00
7.8e-01
-2.3e-01
cases:4.27%
controls:1.59%
cases:3.86%
controls:1.14%
cases:2.44%
controls:0.20%
—
—
cases:1.68%
controls:0.22%
cases:3.08%
controls:1.43%
cases:3.17%
controls:3.98%
21
78
471
4833
19
56
473
4855
12
10
480
4901
—
6
11
351
4898
9
69
283
4756
8
164
244
3957
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
1.0e+00
1.3e+00
2.4e+00
—
2.0e+00
1.1e+00
-8.0e-02
cases:4.27%
controls:1.55%
cases:3.66%
controls:1.02%
cases:2.24%
controls:0.20%
—
—
cases:1.68%
controls:0.22%
cases:3.42%
controls:1.20%
cases:3.57%
controls:3.86%
21
76
471
4835
18
50
474
4861
11
10
481
4901
—
6
11
351
4898
10
58
282
4767
9
159
243
3962
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
48065-7 [3051714]
4.3e-01
1.7e+00
—
1.0e+50
3.6e+00
1.4e+00
8.2e-01
cases:3.86%
controls:2.55%
cases:4.07%
controls:0.79%
—
—
cases:2.64%
controls:0.00%
cases:4.48%
controls:0.12%
cases:4.11%
controls:1.02%
cases:7.54%
controls:3.47%
19
125
473
4786
20
39
472
4872
—
13
0
479
4911
16
6
341
4903
12
49
280
4776
19
143
233
3978
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
1.3e+00
2.5e+00
1.0e+50
1.0e+50
—
2.6e+00
1.6e+00
cases:2.03%
controls:0.59%
cases:2.03%
controls:0.16%
cases:4.27%
controls:0.00%
cases:5.08%
controls:0.00%
—
—
cases:3.77%
controls:0.29%
cases:5.16%
controls:1.09%
10
29
482
4882
10
8
482
4903
21
0
471
4911
25
0
467
4911
—
11
14
281
4811
13
45
239
4076
Cardiology
6 [38004451]
6 [38004451]
5.4e-01
9.2e-01
2.1e+00
1.0e+50
2.1e+00
1.1e+00
4.0e-01
cases:16.06%
controls:10.06%
cases:10.98%
controls:4.66%
cases:4.88%
controls:0.65%
cases:4.67%
controls:0.00%
cases:4.48%
controls:0.57%
cases:13.01%
controls:4.70%
cases:16.67%
controls:11.79%
79
494
413
4417
54
229
438
4682
24
32
468
4879
23
0
469
4911
16
28
341
4881
38
227
254
4598
42
486
210
3635
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
DM1QA [2001301761]
2.2e+00
2.3e+00
—
—
—
—
2.2e+00
cases:1.42%
controls:0.16%
cases:1.42%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.98%
controls:0.22%
7
8
485
4903
7
7
485
4904
—
—
—
—
5
9
247
4112
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
1.3e+00
1.9e+00
—
1.0e+50
—
2.3e+00
1.3e+00
cases:3.66%
controls:1.02%
cases:2.85%
controls:0.45%
—
—
cases:7.32%
controls:0.00%
—
—
cases:5.14%
controls:0.56%
cases:7.14%
controls:2.11%
18
50
474
4861
14
22
478
4889
—
36
0
456
4911
—
15
27
277
4798
18
87
234
4034
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
7.8e-01
1.1e+00
2.8e+00
1.0e+50
2.1e+00
8.6e-01
3.1e-01
cases:7.93%
controls:3.81%
cases:6.30%
controls:2.28%
cases:4.88%
controls:0.33%
cases:1.02%
controls:0.00%
cases:2.80%
controls:0.35%
cases:5.14%
controls:2.24%
cases:7.94%
controls:5.97%
39
187
453
4724
31
112
461
4799
24
16
468
4895
5
0
487
4911
10
17
347
4892
15
108
277
4717
20
246
232
3875
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
6.0e-01
9.8e-01
1.1e+00
—
1.8e+00
1.4e+00
8.7e-01
cases:23.98%
controls:14.80%
cases:21.34%
controls:9.22%
cases:6.50%
controls:2.32%
—
—
cases:9.80%
controls:1.77%
cases:28.08%
controls:9.10%
cases:36.11%
controls:19.17%
118
727
374
4184
105
453
387
4458
32
114
460
4797
—
35
87
322
4822
82
439
210
4386
91
790
161
3331
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
2.4e-01
6.7e-01
2.2e+00
—
2.9e+00
8.4e-01
4.4e-01
cases:11.79%
controls:9.51%
cases:8.74%
controls:4.66%
cases:4.27%
controls:0.49%
—
—
cases:7.56%
controls:0.45%
cases:10.27%
controls:4.73%
cases:20.63%
controls:14.39%
58
467
434
4444
43
229
449
4682
21
24
471
4887
—
27
22
330
4887
30
228
262
4597
52
593
200
3528
Extensive body CT
JN4BD [2001310899]
JN4BD [2001310899]
6.5e-01
2.2e+00
—
1.0e+50
2.5e+00
1.5e+00
1.9e+00
cases:3.05%
controls:1.61%
cases:3.86%
controls:0.45%
—
—
cases:2.03%
controls:0.00%
cases:1.40%
controls:0.12%
cases:2.05%
controls:0.48%
cases:5.16%
controls:0.78%
15
79
477
4832
19
22
473
4889
—
10
0
482
4911
5
6
352
4903
6
23
286
4802
13
32
239
4089
doxycycline; oral, parenteral
J01AA02 [21602800]
J01AA02 [21602800]
5.6e-01
6.9e-01
1.7e+00
—
1.7e+00
1.1e+00
9.0e-01
cases:25.81%
controls:16.55%
cases:9.15%
controls:4.83%
cases:3.25%
controls:0.63%
—
—
cases:3.08%
controls:0.59%
cases:13.70%
controls:5.16%
cases:31.75%
controls:15.92%
127
813
365
4098
45
237
447
4674
16
31
476
4880
—
11
29
346
4880
40
249
252
4576
80
656
172
3465
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
1.3e+00
1.9e+00
—
1.0e+50
—
2.1e+00
1.2e+00
cases:3.25%
controls:0.88%
cases:2.44%
controls:0.39%
—
—
cases:7.11%
controls:0.00%
—
—
cases:4.11%
controls:0.52%
cases:6.35%
controls:1.92%
16
43
476
4868
12
19
480
4892
—
35
0
457
4911
—
12
25
280
4800
16
79
236
4042
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
7.0e-01
1.6e+00
3.3e+00
1.0e+50
—
1.7e+00
6.7e-01
cases:4.07%
controls:2.06%
cases:2.24%
controls:0.47%
cases:2.64%
controls:0.10%
cases:3.05%
controls:0.00%
—
—
cases:3.08%
controls:0.60%
cases:3.57%
controls:1.87%
20
101
472
4810
11
23
481
4888
13
5
479
4906
15
0
477
4911
—
9
29
283
4796
9
77
243
4044
theophylline; oral, parenteral, rectal
R03DA04 [21603332]
R03DA04 [21603332]
1.3e+00
2.0e+00
—
—
—
1.9e+00
1.3e+00
cases:3.05%
controls:0.88%
cases:3.25%
controls:0.47%
—
—
—
—
—
—
cases:3.42%
controls:0.54%
cases:3.97%
controls:1.07%
15
43
477
4868
16
23
476
4888
—
—
—
10
26
282
4799
10
44
242
4077
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
4.5e-01
8.4e-01
1.6e+00
—
1.7e+00
1.0e+00
8.4e-01
cases:37.60%
controls:27.77%
cases:16.87%
controls:8.04%
cases:4.67%
controls:0.94%
—
—
cases:5.04%
controls:1.00%
cases:21.92%
controls:9.22%
cases:46.83%
controls:27.61%
185
1364
307
3547
83
395
409
4516
23
46
469
4865
—
18
49
339
4860
64
445
228
4380
118
1138
134
2983
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
TPH15 [2001309600]
9.0e-01
1.8e+00
1.0e+50
1.0e+50
—
2.8e+00
1.8e+00
cases:1.83%
controls:0.75%
cases:1.42%
controls:0.24%
cases:2.03%
controls:0.00%
cases:2.64%
controls:0.00%
—
—
cases:2.05%
controls:0.12%
cases:3.17%
controls:0.56%
9
37
483
4874
7
12
485
4899
10
0
482
4911
13
0
479
4911
—
6
6
286
4819
8
23
244
4098
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
R91 [45548995]
9.1e-01
2.8e+00
—
—
—
2.2e+00
1.3e+00
cases:2.24%
controls:0.92%
cases:4.67%
controls:0.29%
—
—
—
—
—
—
cases:4.45%
controls:0.50%
cases:4.37%
controls:1.29%
11
45
481
4866
23
14
469
4897
—
—
—
13
24
279
4801
11
53
241
4068
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
26524-9 [3021440]
1.1e+00
9.9e-01
3.4e+00
—
3.0e+00
1.4e+00
1.2e+00
cases:2.24%
controls:0.73%
cases:1.63%
controls:0.61%
cases:2.85%
controls:0.10%
—
—
cases:3.08%
controls:0.16%
cases:2.05%
controls:0.52%
cases:3.97%
controls:1.26%
11
36
481
4875
8
30
484
4881
14
5
478
4906
—
11
8
346
4901
6
25
286
4800
10
52
242
4069
Chronic respiratory failure
J96.1 [45557632]
J96.1 [45557632]
—
—
—
—
—
3.5e+00
2.8e+00
—
—
—
—
—
—
—
—
—
—
cases:4.45%
controls:0.15%
cases:3.57%
controls:0.22%
—
—
—
—
—
13
7
279
4818
9
9
243
4112
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
94500-6 [706163]
3.6e-01
9.9e-01
2.9e+00
1.0e+50
2.3e+00
5.9e-01
3.9e-01
cases:7.32%
controls:5.23%
cases:7.32%
controls:2.85%
cases:8.13%
controls:0.49%
cases:5.08%
controls:0.00%
cases:5.32%
controls:0.55%
cases:5.14%
controls:2.90%
cases:13.10%
controls:9.25%
36
257
456
4654
36
140
456
4771
40
24
452
4887
25
0
467
4911
19
27
338
4882
15
140
277
4685
33
381
219
3740
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
14933-6 [3026493]
5.8e-01
1.3e+00
2.3e+00
—
2.5e+00
8.2e-01
6.5e-01
cases:7.52%
controls:4.34%
cases:5.69%
controls:1.63%
cases:1.63%
controls:0.16%
—
—
cases:2.24%
controls:0.18%
cases:3.77%
controls:1.70%
cases:10.71%
controls:5.87%
37
213
455
4698
28
80
464
4831
8
8
484
4903
—
8
9
349
4900
11
82
281
4743
27
242
225
3879
EKG study
11524-6 [3013512]
11524-6 [3013512]
3.0e-01
7.4e-01
2.6e+00
1.0e+50
2.8e+00
8.1e-01
2.2e-01
cases:6.50%
controls:4.91%
cases:5.89%
controls:2.91%
cases:4.88%
controls:0.39%
cases:2.85%
controls:0.00%
cases:4.20%
controls:0.26%
cases:6.85%
controls:3.17%
cases:10.71%
controls:8.76%
32
241
460
4670
29
143
463
4768
24
19
468
4892
14
0
478
4911
15
13
342
4896
20
153
272
4672
27
361
225
3760
Monitored bed care
WX892 [2001310850]
WX892 [2001310850]
1.5e+00
2.2e+00
—
1.0e+50
—
2.3e+00
1.4e+00
cases:2.85%
controls:0.63%
cases:2.64%
controls:0.29%
—
—
cases:4.07%
controls:0.00%
—
—
cases:3.08%
controls:0.31%
cases:3.57%
controls:0.92%
14
31
478
4880
13
14
479
4897
—
20
0
472
4911
—
9
15
283
4810
9
38
243
4083
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
8.4e-01
2.0e+00
—
1.0e+50
1.0e+50
2.4e+00
1.7e+00
cases:1.22%
controls:0.53%
cases:1.63%
controls:0.22%
—
—
cases:3.05%
controls:0.00%
cases:3.36%
controls:0.00%
cases:2.40%
controls:0.23%
cases:4.76%
controls:0.90%
6
26
486
4885
8
11
484
4900
—
15
0
477
4911
12
0
345
4909
7
11
285
4814
12
37
240
4084
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
FB1BD [2001302407]
1.6e+00
2.5e+00
1.0e+50
1.0e+50
—
2.0e+00
8.6e-01
cases:3.46%
controls:0.75%
cases:2.03%
controls:0.16%
cases:3.25%
controls:0.00%
cases:4.07%
controls:0.00%
—
—
cases:2.05%
controls:0.29%
cases:2.38%
controls:1.02%
17
37
475
4874
10
8
482
4903
16
0
476
4911
20
0
472
4911
—
6
14
286
4811
6
42
246
4079
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
8.2e-01
1.3e+00
1.3e+00
—
1.5e+00
1.4e+00
1.2e+00
cases:7.52%
controls:3.46%
cases:6.10%
controls:1.79%
cases:2.24%
controls:0.61%
—
—
cases:2.24%
controls:0.53%
cases:7.53%
controls:1.89%
cases:12.30%
controls:3.98%
37
170
455
4741
30
88
462
4823
11
30
481
4881
—
8
26
349
4883
22
91
270
4734
31
164
221
3957
Spirometry
127783003 [4133840]
127783003 [4133840]
—
—
—
—
—
3.7e+00
2.3e+00
—
—
—
—
—
—
—
—
—
—
cases:4.79%
controls:0.12%
cases:4.76%
controls:0.49%
—
—
—
—
—
14
6
278
4819
12
20
240
4101
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
3.6e-01
9.9e-01
3.5e+00
—
1.5e+00
6.7e-01
1.7e-01
cases:8.54%
controls:6.09%
cases:9.15%
controls:3.60%
cases:8.94%
controls:0.31%
—
—
cases:3.08%
controls:0.67%
cases:8.22%
controls:4.37%
cases:14.68%
controls:12.72%
42
299
450
4612
45
177
447
4734
44
15
448
4896
—
11
33
346
4876
24
211
268
4614
37
524
215
3597
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
TNX10 [2001308560]
1.8e+00
2.0e+00
—
—
—
—
2.1e+00
cases:2.03%
controls:0.33%
cases:1.22%
controls:0.16%
—
—
—
—
—
—
—
—
cases:2.78%
controls:0.34%
10
16
482
4895
6
8
486
4903
—
—
—
—
7
14
245
4107
Bacteria identified in Sputum by Culture
6460-0 [3023419]
6460-0 [3023419]
—
—
1.0e+50
—
1.0e+50
2.8e+00
3.2e+00
—
—
—
—
cases:2.24%
controls:0.00%
—
—
cases:4.20%
controls:0.00%
cases:1.71%
controls:0.10%
cases:2.78%
controls:0.12%
—
—
11
0
481
4911
—
15
0
342
4909
5
5
287
4820
7
5
245
4116
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
1.0e+00
1.6e+00
—
—
—
1.9e+00
1.4e+00
cases:5.28%
controls:1.98%
cases:3.46%
controls:0.71%
—
—
—
—
—
—
cases:4.45%
controls:0.66%
cases:9.92%
controls:2.67%
26
97
466
4814
17
35
475
4876
—
—
—
13
32
279
4793
25
110
227
4011
moxifloxacin; oral, parenteral
J01MA14 [21603021]
J01MA14 [21603021]
9.5e-01
2.2e+00
—
—
—
2.4e+00
1.4e+00
cases:2.64%
controls:1.04%
cases:2.44%
controls:0.29%
—
—
—
—
—
—
cases:3.08%
controls:0.29%
cases:4.37%
controls:1.14%
13
51
479
4860
12
14
480
4897
—
—
—
9
14
283
4811
11
47
241
4074
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
J01MA02 [21603009]
-8.5e-02
7.1e-01
2.7e+00
—
2.2e+00
9.9e-01
5.6e-01
cases:5.49%
controls:5.95%
cases:3.86%
controls:1.93%
cases:1.83%
controls:0.12%
—
—
cases:1.96%
controls:0.22%
cases:5.82%
controls:2.24%
cases:11.11%
controls:6.65%
27
292
465
4619
19
95
473
4816
9
6
483
4905
—
7
11
350
4898
17
108
275
4717
28
274
224
3847
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
3.6e-01
9.7e-01
3.5e+00
—
1.4e+00
6.5e-01
9.4e-03
cases:8.33%
controls:5.99%
cases:8.94%
controls:3.58%
cases:8.94%
controls:0.31%
—
—
cases:2.80%
controls:0.67%
cases:7.88%
controls:4.27%
cases:12.70%
controls:12.59%
41
294
451
4617
44
176
448
4735
44
15
448
4896
—
10
33
347
4876
23
206
269
4619
32
519
220
3602
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
4.1e-01
1.0e+00
3.5e+00
—
1.4e+00
6.7e-01
1.2e-01
cases:9.15%
controls:6.27%
cases:9.35%
controls:3.67%
cases:8.94%
controls:0.31%
—
—
cases:2.80%
controls:0.69%
cases:8.22%
controls:4.39%
cases:14.29%
controls:12.89%
45
308
447
4603
46
180
446
4731
44
15
448
4896
—
10
34
347
4875
24
212
268
4613
36
531
216
3590
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
5.3e-01
9.9e-01
2.4e+00
—
2.3e+00
1.1e+00
1.1e+00
cases:3.25%
controls:1.93%
cases:1.63%
controls:0.61%
cases:1.63%
controls:0.14%
—
—
cases:1.40%
controls:0.14%
cases:2.05%
controls:0.70%
cases:6.35%
controls:2.23%
16
95
476
4816
8
30
484
4881
8
7
484
4904
—
5
7
352
4902
6
34
286
4791
16
92
236
4029
temazepam; oral
N05CD07 [21604642]
N05CD07 [21604642]
9.7e-01
8.7e-01
—
—
1.7e+00
1.3e+00
9.5e-01
cases:8.13%
controls:3.26%
cases:4.88%
controls:2.10%
—
—
—
—
cases:2.24%
controls:0.43%
cases:6.51%
controls:1.89%
cases:8.73%
controls:3.57%
40
160
452
4751
24
103
468
4808
—
—
8
21
349
4888
19
91
273
4734
22
147
230
3974
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
29257-3 [3002482]
2.9e+00
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
2.8e+00
cases:1.83%
controls:0.10%
—
—
cases:4.27%
controls:0.00%
cases:1.02%
controls:0.00%
cases:7.00%
controls:0.00%
cases:2.05%
controls:0.00%
cases:5.16%
controls:0.32%
9
5
483
4906
—
21
0
471
4911
5
0
487
4911
25
0
332
4909
6
0
286
4825
13
13
239
4108
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
1.0e+00
1.5e+00
—
—
—
2.0e+00
1.2e+00
cases:5.08%
controls:1.93%
cases:4.67%
controls:1.10%
—
—
—
—
—
—
cases:7.53%
controls:1.06%
cases:10.32%
controls:3.35%
25
95
467
4816
23
54
469
4857
—
—
—
22
51
270
4774
26
138
226
3983
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
1.1e+00
1.6e+00
—
—
—
2.0e+00
1.0e+00
cases:4.88%
controls:1.75%
cases:4.47%
controls:0.98%
—
—
—
—
—
—
cases:6.85%
controls:0.95%
cases:7.94%
controls:2.96%
24
86
468
4825
22
48
470
4863
—
—
—
20
46
272
4779
20
122
232
3999
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
9.7e-01
1.5e+00
—
1.0e+50
—
1.9e+00
1.3e+00
cases:4.27%
controls:1.67%
cases:2.85%
controls:0.65%
—
—
cases:1.42%
controls:0.00%
—
—
cases:3.08%
controls:0.48%
cases:8.33%
controls:2.38%
21
82
471
4829
14
32
478
4879
—
7
0
485
4911
—
9
23
283
4802
21
98
231
4023
General Practice Dentistry
1223G0001X [38003675]
1223G0001X [38003675]
—
2.4e+00
—
—
—
—
3.2e+00
—
—
cases:1.83%
controls:0.16%
—
—
—
—
—
—
—
—
cases:3.57%
controls:0.15%
—
9
8
483
4903
—
—
—
—
9
6
243
4115
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
1.0e+00
1.6e+00
—
—
—
2.0e+00
1.1e+00
cases:4.67%
controls:1.73%
cases:4.47%
controls:0.98%
—
—
—
—
—
—
cases:6.51%
controls:0.91%
cases:7.54%
controls:2.74%
23
85
469
4826
22
48
470
4863
—
—
—
19
44
273
4781
19
113
233
4008
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
62424-7 [40765161]
2.6e+00
—
1.0e+50
—
1.0e+50
1.0e+50
3.1e+00
cases:1.83%
controls:0.14%
—
—
cases:3.86%
controls:0.00%
—
—
cases:4.48%
controls:0.00%
cases:2.40%
controls:0.00%
cases:3.97%
controls:0.19%
9
7
483
4904
—
19
0
473
4911
—
16
0
341
4909
7
0
285
4825
10
8
242
4113
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 [3012477]
23826-1 [3012477]
2.6e+00
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
2.9e+00
cases:1.42%
controls:0.10%
—
—
cases:3.66%
controls:0.00%
cases:1.02%
controls:0.00%
cases:7.00%
controls:0.00%
cases:2.05%
controls:0.00%
cases:4.37%
controls:0.24%
7
5
485
4906
—
18
0
474
4911
5
0
487
4911
25
0
332
4909
6
0
286
4825
11
10
241
4111
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
38917-1 [3042194]
2.5e+00
—
1.0e+50
1.0e+50
1.0e+50
—
3.1e+00
cases:2.24%
controls:0.18%
—
—
cases:5.49%
controls:0.00%
cases:1.63%
controls:0.00%
cases:7.00%
controls:0.00%
—
—
cases:6.75%
controls:0.34%
11
9
481
4902
—
27
0
465
4911
8
0
484
4911
25
0
332
4909
—
17
14
235
4107
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
2.4e+00
—
—
—
—
—
3.1e+00
cases:1.63%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:3.17%
controls:0.15%
8
7
484
4904
—
—
—
—
—
8
6
244
4115
Body CT examination
JN4AD [2001310897]
JN4AD [2001310897]
8.3e-01
2.0e+00
3.5e+00
1.0e+50
—
—
3.1e-01
cases:1.63%
controls:0.71%
cases:2.44%
controls:0.33%
cases:3.25%
controls:0.10%
cases:3.66%
controls:0.00%
—
—
—
—
cases:1.98%
controls:1.46%
8
35
484
4876
12
16
480
4895
16
5
476
4906
18
0
474
4911
—
—
5
60
247
4061
Bone marrow biopsy
XW000 [2001310618]
XW000 [2001310618]
1.3e+00
2.3e+00
—
—
—
3.2e+00
—
cases:1.83%
controls:0.49%
cases:2.44%
controls:0.24%
—
—
—
—
—
—
cases:2.40%
controls:0.10%
—
—
9
24
483
4887
12
12
480
4899
—
—
—
7
5
285
4820
—
Medical Oncology
90 [38004507]
90 [38004507]
3.2e-01
1.2e+00
1.6e+00
2.7e+00
5.7e-01
6.6e-01
3.8e-01
cases:4.88%
controls:3.60%
cases:7.72%
controls:2.52%
cases:4.27%
controls:0.92%
cases:1.83%
controls:0.12%
cases:1.68%
controls:0.96%
cases:5.14%
controls:2.72%
cases:6.35%
controls:4.44%
24
177
468
4734
38
124
454
4787
21
45
471
4866
9
6
483
4905
6
47
351
4862
15
131
277
4694
16
183
236
3938
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
1.6e+00
2.0e+00
—
1.0e+50
—
1.8e+00
8.2e-01
cases:3.46%
controls:0.69%
cases:3.46%
controls:0.47%
—
—
cases:1.22%
controls:0.00%
—
—
cases:2.40%
controls:0.41%
cases:3.57%
controls:1.60%
17
34
475
4877
17
23
475
4888
—
6
0
486
4911
—
7
20
285
4805
9
66
243
4055
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
40976-3 [3040853]
2.5e+00
—
1.0e+50
1.0e+50
1.0e+50
—
2.9e+00
cases:2.24%
controls:0.18%
—
—
cases:5.89%
controls:0.00%
cases:1.42%
controls:0.00%
cases:8.40%
controls:0.00%
—
—
cases:6.35%
controls:0.39%
11
9
481
4902
—
29
0
463
4911
7
0
485
4911
30
0
327
4909
—
16
16
236
4105
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
1.4e+00
1.7e+00
—
1.0e+50
—
2.2e+00
1.3e+00
cases:2.44%
controls:0.61%
cases:1.63%
controls:0.31%
—
—
cases:2.44%
controls:0.00%
—
—
cases:3.77%
controls:0.41%
cases:3.57%
controls:1.04%
12
30
480
4881
8
15
484
4896
—
12
0
480
4911
—
11
20
281
4805
9
43
243
4078
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 [3031478]
34645-2 [3031478]
2.5e+00
—
1.0e+50
—
1.0e+50
—
2.8e+00
cases:1.22%
controls:0.10%
—
—
cases:3.86%
controls:0.00%
—
—
cases:4.76%
controls:0.00%
—
—
cases:4.37%
controls:0.27%
6
5
486
4906
—
19
0
473
4911
—
17
0
340
4909
—
11
11
241
4110
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2614-6 [3007930]
1.5e+00
2.6e+00
—
1.0e+50
—
2.7e+00
1.4e+00
cases:1.42%
controls:0.33%
cases:1.42%
controls:0.10%
—
—
cases:4.27%
controls:0.00%
—
—
cases:2.05%
controls:0.15%
cases:3.17%
controls:0.78%
7
16
485
4895
7
5
485
4906
—
21
0
471
4911
—
6
7
286
4818
8
32
244
4089
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
4.2e-01
4.8e-01
1.8e+00
—
1.9e+00
6.7e-01
3.5e-01
cases:23.58%
controls:16.80%
cases:13.82%
controls:9.02%
cases:6.30%
controls:1.12%
—
—
cases:8.40%
controls:1.30%
cases:17.81%
controls:9.99%
cases:31.75%
controls:24.70%
116
825
376
4086
68
443
424
4468
31
55
461
4856
—
30
64
327
4845
52
482
240
4343
80
1018
172
3103
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
14675-3 [3036481]
9.7e-01
1.6e+00
—
—
—
2.0e+00
1.7e+00
cases:2.24%
controls:0.86%
cases:2.24%
controls:0.45%
—
—
—
—
—
—
cases:3.08%
controls:0.44%
cases:5.16%
controls:1.02%
11
42
481
4869
11
22
481
4889
—
—
—
9
21
283
4804
13
42
239
4079
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
2.6e-01
7.2e-01
3.2e+00
—
2.0e+00
8.4e-01
3.3e-01
cases:4.27%
controls:3.34%
cases:3.66%
controls:1.81%
cases:3.86%
controls:0.16%
—
—
cases:1.96%
controls:0.26%
cases:4.45%
controls:1.97%
cases:8.33%
controls:6.12%
21
164
471
4747
18
89
474
4822
19
8
473
4903
—
7
13
350
4896
13
95
279
4730
21
252
231
3869
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
4498-2 [3017766]
2.5e+00
2.7e+00
—
—
1.0e+50
—
—
cases:2.03%
controls:0.16%
cases:2.03%
controls:0.14%
—
—
—
—
cases:2.52%
controls:0.00%
—
—
—
—
10
8
482
4903
10
7
482
4904
—
—
9
0
348
4909
—
—
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
7.2e-01
1.4e+00
3.8e+00
—
—
1.2e+00
9.2e-01
cases:3.25%
controls:1.61%
cases:2.44%
controls:0.63%
cases:4.47%
controls:0.10%
—
—
—
—
cases:2.74%
controls:0.87%
cases:6.35%
controls:2.62%
16
79
476
4832
12
31
480
4880
22
5
470
4906
—
—
8
42
284
4783
16
108
236
4013
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
9.7e-01
2.1e+00
—
—
—
2.1e+00
1.2e+00
cases:3.25%
controls:1.26%
cases:2.64%
controls:0.35%
—
—
—
—
—
—
cases:2.40%
controls:0.29%
cases:4.37%
controls:1.41%
16
62
476
4849
13
17
479
4894
—
—
—
7
14
285
4811
11
58
241
4063
potassium chloride; oral
A12BA01 [21600877]
A12BA01 [21600877]
8.3e-01
1.4e+00
—
—
1.8e+00
1.8e+00
1.1e+00
cases:4.47%
controls:2.00%
cases:3.86%
controls:1.02%
—
—
—
—
cases:1.68%
controls:0.29%
cases:6.85%
controls:1.16%
cases:8.73%
controls:3.03%
22
98
470
4813
19
50
473
4861
—
—
6
14
351
4895
20
56
272
4769
22
125
230
3996
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
3.7e-01
7.5e-01
2.2e+00
—
2.2e+00
6.5e-01
6.1e-01
cases:7.93%
controls:5.60%
cases:9.15%
controls:4.56%
cases:7.11%
controls:0.81%
—
—
cases:8.68%
controls:1.08%
cases:8.90%
controls:4.87%
cases:14.68%
controls:8.59%
39
275
453
4636
45
224
447
4687
35
40
457
4871
—
31
53
326
4856
26
235
266
4590
37
354
215
3767
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
48404-8 [3049804]
2.5e+00
2.6e+00
—
—
1.0e+50
—
—
cases:2.64%
controls:0.22%
cases:1.42%
controls:0.10%
—
—
—
—
cases:1.68%
controls:0.00%
—
—
—
—
13
11
479
4900
7
5
485
4906
—
—
6
0
351
4909
—
—
filgrastim; parenteral
L03AA02 [21603851]
L03AA02 [21603851]
2.2e+00
2.9e+00
—
—
—
—
—
cases:1.42%
controls:0.16%
cases:1.83%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
7
8
485
4903
9
5
483
4906
—
—
—
—
—
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
8.3e-02
8.0e-01
2.6e+00
1.0e+50
—
1.4e+00
1.1e+00
cases:7.52%
controls:6.96%
cases:3.66%
controls:1.67%
cases:3.05%
controls:0.24%
cases:1.02%
controls:0.00%
—
—
cases:5.82%
controls:1.43%
cases:13.10%
controls:5.00%
37
342
455
4569
18
82
474
4829
15
12
477
4899
5
0
487
4911
—
17
69
275
4756
33
206
219
3915
Nonallergic asthma
J45.1 [45557625]
J45.1 [45557625]
1.2e+00
1.7e+00
—
—
—
2.1e+00
1.3e+00
cases:3.05%
controls:0.92%
cases:1.83%
controls:0.33%
—
—
—
—
—
—
cases:3.08%
controls:0.39%
cases:3.17%
controls:0.87%
15
45
477
4866
9
16
483
4895
—
—
—
9
19
283
4806
8
36
244
4085
Obstetrics / Gynecology
16 [38004461]
16 [38004461]
6.1e-02
5.5e-01
1.5e+00
—
1.8e+00
9.7e-01
7.4e-01
cases:8.74%
controls:8.27%
cases:5.08%
controls:2.99%
cases:2.85%
controls:0.65%
—
—
cases:3.08%
controls:0.51%
cases:6.51%
controls:2.57%
cases:13.10%
controls:6.72%
43
406
449
4505
25
147
467
4764
14
32
478
4879
—
11
25
346
4884
19
124
273
4701
33
277
219
3844
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
20563-3 [3023081]
1.4e+00
2.5e+00
—
1.0e+50
—
2.5e+00
1.3e+00
cases:1.42%
controls:0.37%
cases:1.22%
controls:0.10%
—
—
cases:4.47%
controls:0.00%
—
—
cases:2.05%
controls:0.17%
cases:3.17%
controls:0.85%
7
18
485
4893
6
5
486
4906
—
22
0
470
4911
—
6
8
286
4817
8
35
244
4086
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
1.2e+00
1.9e+00
—
—
—
1.8e+00
1.0e+00
cases:3.66%
controls:1.08%
cases:3.25%
controls:0.49%
—
—
—
—
—
—
cases:3.42%
controls:0.56%
cases:5.16%
controls:1.94%
18
53
474
4858
16
24
476
4887
—
—
—
10
27
282
4798
13
80
239
4041
calcium (different salts in combination); oral
A12AA20 [21600872]
A12AA20 [21600872]
7.6e-01
8.7e-01
9.8e-01
—
2.0e-01
1.2e+00
1.1e+00
cases:13.41%
controls:6.78%
cases:12.40%
controls:5.58%
cases:3.46%
controls:1.32%
—
—
cases:1.68%
controls:1.39%
cases:17.81%
controls:5.93%
cases:23.81%
controls:9.03%
66
333
426
4578
61
274
431
4637
17
65
475
4846
—
6
68
351
4841
52
286
240
4539
60
372
192
3749
Morphology [Interpretation] in Bone marrow Narrative
51628-6 [3042111]
51628-6 [3042111]
1.7e+00
2.2e+00
—
—
—
2.8e+00
—
cases:1.22%
controls:0.22%
cases:1.22%
controls:0.14%
—
—
—
—
—
—
cases:1.71%
controls:0.10%
—
—
6
11
486
4900
6
7
486
4904
—
—
—
5
5
287
4820
—
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
5.6e-01
6.7e-01
2.9e+00
1.0e+50
2.1e+00
6.5e-01
5.9e-01
cases:5.49%
controls:3.20%
cases:3.25%
controls:1.69%
cases:3.46%
controls:0.20%
cases:1.02%
controls:0.00%
cases:1.96%
controls:0.24%
cases:3.42%
controls:1.82%
cases:7.14%
controls:4.08%
27
157
465
4754
16
83
476
4828
17
10
475
4901
5
0
487
4911
7
12
350
4897
10
88
282
4737
18
168
234
3953
Myeloperoxidase Ab [Units/volume] in Serum
6969-0 [3023150]
6969-0 [3023150]
2.3e+00
2.6e+00
1.0e+50
—
1.0e+50
—
—
cases:1.22%
controls:0.12%
cases:1.42%
controls:0.10%
cases:1.83%
controls:0.00%
—
—
cases:2.80%
controls:0.00%
—
—
—
—
6
6
486
4905
7
5
485
4906
9
0
483
4911
—
10
0
347
4909
—
—
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
5.7e-01
8.4e-01
2.8e+00
—
2.1e+00
9.1e-01
5.5e-01
cases:5.49%
controls:3.18%
cases:3.25%
controls:1.43%
cases:2.64%
controls:0.16%
—
—
cases:1.68%
controls:0.20%
cases:3.08%
controls:1.26%
cases:5.95%
controls:3.52%
27
156
465
4755
16
70
476
4841
13
8
479
4903
—
6
10
351
4899
9
61
283
4764
15
145
237
3976
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
4.8e-01
9.9e-01
2.2e+00
—
1.5e+00
1.0e+00
7.1e-01
cases:13.01%
controls:8.47%
cases:8.74%
controls:3.44%
cases:4.27%
controls:0.51%
—
—
cases:2.24%
controls:0.49%
cases:9.59%
controls:3.63%
cases:18.25%
controls:9.85%
64
416
428
4495
43
169
449
4742
21
25
471
4886
—
8
24
349
4885
28
175
264
4650
46
406
206
3715
Immunofixation for Serum or Plasma
25700-6 [3037756]
25700-6 [3037756]
2.6e+00
2.3e+00
—
—
—
—
—
cases:1.83%
controls:0.14%
cases:1.42%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
9
7
483
4904
7
7
485
4904
—
—
—
—
—
quetiapine; oral
N05AH04 [21604544]
N05AH04 [21604544]
9.3e-01
1.3e+00
1.4e+00
—
1.3e+00
1.6e+00
1.0e+00
cases:5.28%
controls:2.16%
cases:4.88%
controls:1.38%
cases:1.63%
controls:0.39%
—
—
cases:1.40%
controls:0.39%
cases:7.19%
controls:1.51%
cases:7.54%
controls:2.84%
26
106
466
4805
24
68
468
4843
8
19
484
4892
—
5
19
352
4890
21
73
271
4752
19
117
233
4004
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
6.9e-01
1.6e+00
—
—
—
1.5e+00
1.1e+00
cases:6.50%
controls:3.38%
cases:4.47%
controls:0.98%
—
—
—
—
—
—
cases:3.42%
controls:0.79%
cases:9.92%
controls:3.45%
32
166
460
4745
22
48
470
4863
—
—
—
10
38
282
4787
25
142
227
3979
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
3255-7 [3016407]
1.8e+00
3.0e+00
—
—
—
—
1.6e+00
cases:1.83%
controls:0.31%
cases:2.44%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.98%
controls:0.41%
9
15
483
4896
12
6
480
4905
—
—
—
—
5
17
247
4104
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
FM1EE [2001303307]
8.1e-01
1.6e+00
1.8e+00
1.0e+50
—
1.6e+00
8.0e-01
cases:6.30%
controls:2.89%
cases:5.08%
controls:1.12%
cases:1.02%
controls:0.16%
cases:4.47%
controls:0.00%
—
—
cases:7.19%
controls:1.49%
cases:8.73%
controls:4.13%
31
142
461
4769
25
55
467
4856
5
8
487
4903
22
0
470
4911
—
21
72
271
4753
22
170
230
3951
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
3.1e-01
1.1e+00
3.7e+00
—
1.1e+00
8.3e-01
1.7e-01
cases:6.50%
controls:4.87%
cases:7.52%
controls:2.67%
cases:6.91%
controls:0.18%
—
—
cases:1.68%
controls:0.55%
cases:6.51%
controls:2.94%
cases:11.11%
controls:9.56%
32
239
460
4672
37
131
455
4780
34
9
458
4902
—
6
27
351
4882
19
142
273
4683
28
394
224
3727
Lactate [Moles/volume] in Blood
32693-4 [3047181]
32693-4 [3047181]
1.4e+00
—
1.0e+50
1.0e+50
—
3.0e+00
1.8e+00
cases:1.42%
controls:0.35%
—
—
cases:2.24%
controls:0.00%
cases:3.86%
controls:0.00%
—
—
cases:2.74%
controls:0.15%
cases:3.57%
controls:0.61%
7
17
485
4894
—
11
0
481
4911
19
0
473
4911
—
8
7
284
4818
9
25
243
4096
Acute bronchitis, unspecified
J20.9 [45562445]
J20.9 [45562445]
7.1e-01
1.4e+00
—
—
—
2.0e+00
1.4e+00
cases:3.86%
controls:1.93%
cases:2.24%
controls:0.55%
—
—
—
—
—
—
cases:4.45%
controls:0.64%
cases:9.92%
controls:2.74%
19
95
473
4816
11
27
481
4884
—
—
—
13
31
279
4794
25
113
227
4008
warfarin; oral, parenteral
B01AA03 [21600965]
B01AA03 [21600965]
6.3e-01
5.9e-01
6.2e-01
—
1.7e+00
1.0e+00
7.6e-01
cases:12.40%
controls:7.03%
cases:9.96%
controls:5.76%
cases:2.44%
controls:1.32%
—
—
cases:7.28%
controls:1.36%
cases:14.73%
controls:5.80%
cases:15.08%
controls:7.69%
61
345
431
4566
49
283
443
4628
12
65
480
4846
—
26
67
331
4842
43
280
249
4545
38
317
214
3804
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
2.4e-01
8.7e-01
3.9e+00
—
1.6e+00
6.1e-01
1.7e-01
cases:5.08%
controls:4.05%
cases:4.67%
controls:2.02%
cases:4.67%
controls:0.10%
—
—
cases:1.68%
controls:0.35%
cases:4.79%
controls:2.67%
cases:8.33%
controls:7.13%
25
199
467
4712
23
99
469
4812
23
5
469
4906
—
6
17
351
4892
14
129
278
4696
21
294
231
3827
Social worker
Z2446 [2001311559]
Z2446 [2001311559]
7.4e-01
—
—
—
—
3.1e+00
1.6e+00
cases:1.02%
controls:0.49%
—
—
—
—
—
—
—
—
cases:3.08%
controls:0.15%
cases:3.17%
controls:0.63%
5
24
487
4887
—
—
—
—
9
7
283
4818
8
26
244
4095
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
8.3e-01
1.9e+00
—
—
—
1.7e+00
1.1e+00
cases:3.66%
controls:1.63%
cases:3.25%
controls:0.51%
—
—
—
—
—
—
cases:3.08%
controls:0.58%
cases:5.56%
controls:1.89%
18
80
474
4831
16
25
476
4886
—
—
—
9
28
283
4797
14
78
238
4043
Noninvasive ventilation
WX725 [2001310828]
WX725 [2001310828]
1.2e+00
1.7e+00
1.0e+50
1.0e+50
—
2.5e+00
2.1e+00
cases:1.22%
controls:0.37%
cases:1.02%
controls:0.18%
cases:1.22%
controls:0.00%
cases:2.03%
controls:0.00%
—
—
cases:2.05%
controls:0.17%
cases:3.57%
controls:0.44%
6
18
486
4893
5
9
487
4902
6
0
486
4911
10
0
482
4911
—
6
8
286
4817
9
18
243
4103
oxazepam; oral
N05BA04 [21604569]
N05BA04 [21604569]
1.1e+00
1.3e+00
1.2e+00
—
8.9e-01
1.3e+00
9.5e-01
cases:9.96%
controls:3.67%
cases:8.13%
controls:2.32%
cases:2.24%
controls:0.69%
—
—
cases:1.96%
controls:0.81%
cases:9.59%
controls:2.72%
cases:11.90%
controls:4.97%
49
180
443
4731
40
114
452
4797
11
34
481
4877
—
7
40
350
4869
28
131
264
4694
30
205
222
3916
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
4485-9 [3000620]
2.2e+00
2.4e+00
—
—
1.0e+50
—
—
cases:1.83%
controls:0.20%
cases:2.03%
controls:0.18%
—
—
—
—
cases:2.52%
controls:0.00%
—
—
—
—
9
10
483
4901
10
9
482
4902
—
—
9
0
348
4909
—
—
Angiography of heart and/or coronary arteries
FN1AC [2001302996]
FN1AC [2001302996]
6.7e-01
1.2e+00
2.8e+00
1.0e+50
—
7.2e-01
3.7e-01
cases:6.71%
controls:3.56%
cases:3.86%
controls:1.22%
cases:1.63%
controls:0.10%
cases:1.22%
controls:0.00%
—
—
cases:2.05%
controls:1.02%
cases:5.16%
controls:3.62%
33
175
459
4736
19
60
473
4851
8
5
484
4906
6
0
486
4911
—
6
49
286
4776
13
149
239
3972
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
14278-6 [3003284]
14278-6 [3003284]
2.1e+00
2.5e+00
—
—
1.0e+50
—
—
cases:1.63%
controls:0.20%
cases:1.22%
controls:0.10%
—
—
—
—
cases:2.52%
controls:0.00%
—
—
—
—
8
10
484
4901
6
5
486
4906
—
—
9
0
348
4909
—
—
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14277-8 [3004383]
14277-8 [3004383]
2.1e+00
2.5e+00
—
—
1.0e+50
—
—
cases:1.63%
controls:0.20%
cases:1.22%
controls:0.10%
—
—
—
—
cases:2.52%
controls:0.00%
—
—
—
—
8
10
484
4901
6
5
486
4906
—
—
9
0
348
4909
—
—
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
2865-4 [3015322]
2.1e+00
2.5e+00
—
—
—
—
—
cases:2.24%
controls:0.29%
cases:1.42%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
11
14
481
4897
7
6
485
4905
—
—
—
—
—
Triglyceride [Moles/volume] in Serum or Plasma
14927-8 [3025839]
14927-8 [3025839]
8.0e-01
6.6e-01
2.3e+00
—
2.2e+00
2.2e-02
-1.4e-01
cases:3.46%
controls:1.59%
cases:3.46%
controls:1.81%
cases:1.22%
controls:0.12%
—
—
cases:1.68%
controls:0.18%
cases:2.05%
controls:2.01%
cases:5.95%
controls:6.77%
17
78
475
4833
17
89
475
4822
6
6
486
4905
—
6
9
351
4900
6
97
286
4728
15
279
237
3842
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
1.3e+00
1.9e+00
—
1.0e+50
—
—
1.4e+00
cases:3.05%
controls:0.88%
cases:2.44%
controls:0.39%
—
—
cases:2.24%
controls:0.00%
—
—
—
—
cases:5.95%
controls:1.53%
15
43
477
4868
12
19
480
4892
—
11
0
481
4911
—
—
15
63
237
4058
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
5.9e-01
9.9e-01
1.2e+00
—
1.2e+00
1.0e+00
6.8e-01
cases:11.79%
controls:6.92%
cases:8.94%
controls:3.52%
cases:3.05%
controls:0.90%
—
—
cases:2.52%
controls:0.77%
cases:9.93%
controls:3.79%
cases:14.68%
controls:7.98%
58
340
434
4571
44
173
448
4738
15
44
477
4867
—
9
38
348
4871
29
183
263
4642
37
329
215
3792
Chronic lymphocytic leukaemia of B-cell type
C91.1 [45600564]
C91.1 [45600564]
2.2e+00
2.3e+00
—
1.0e+50
—
—
—
cases:1.63%
controls:0.18%
cases:1.63%
controls:0.16%
—
—
cases:1.02%
controls:0.00%
—
—
—
—
—
—
8
9
484
4902
8
8
484
4903
—
5
0
487
4911
—
—
—
Phlebitis and thrombophlebitis of lower extremities, unspecified
I80.3 [45572137]
I80.3 [45572137]
—
2.3e+00
—
—
—
—
2.2e+00
—
—
cases:1.22%
controls:0.12%
—
—
—
—
—
—
—
—
cases:3.17%
controls:0.36%
—
6
6
486
4905
—
—
—
—
8
15
244
4106
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
43730-1 [3043849]
2.1e+00
—
—
—
—
—
2.4e+00
cases:1.63%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:2.38%
controls:0.22%
8
10
484
4901
—
—
—
—
—
6
9
246
4112
Treatment plan or consultation
WZC00 [2001310885]
WZC00 [2001310885]
4.5e-01
1.1e+00
—
—
2.6e+00
8.8e-01
7.5e-01
cases:5.89%
controls:3.83%
cases:4.27%
controls:1.45%
—
—
—
—
cases:1.68%
controls:0.12%
cases:4.11%
controls:1.74%
cases:10.32%
controls:5.14%
29
188
463
4723
21
71
471
4840
—
—
6
6
351
4903
12
84
280
4741
26
212
226
3909
Unspecified acute lower respiratory infection
J22 [45586665]
J22 [45586665]
2.4e+00
—
—
—
—
—
2.0e+00
cases:2.03%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:3.97%
controls:0.53%
10
9
482
4902
—
—
—
—
—
10
22
242
4099
Chronic ischaemic heart disease, unspecified
I25.9 [45552784]
I25.9 [45552784]
7.5e-01
1.2e+00
2.4e+00
1.0e+50
2.0e+00
1.2e+00
2.1e-01
cases:2.85%
controls:1.36%
cases:2.24%
controls:0.71%
cases:1.83%
controls:0.16%
cases:1.83%
controls:0.00%
cases:1.96%
controls:0.26%
cases:2.74%
controls:0.85%
cases:3.17%
controls:2.60%
14
67
478
4844
11
35
481
4876
9
8
483
4903
9
0
483
4911
7
13
350
4896
8
41
284
4784
8
107
244
4014
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
32731-2 [3043747]
2.1e+00
2.3e+00
—
—
—
—
—
cases:2.44%
controls:0.31%
cases:1.42%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
12
15
480
4896
7
7
485
4904
—
—
—
—
—
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
2868-8 [3005229]
2.1e+00
2.3e+00
—
—
—
—
—
cases:2.44%
controls:0.31%
cases:1.42%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
12
15
480
4896
7
7
485
4904
—
—
—
—
—
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
2874-6 [3023465]
2.1e+00
2.3e+00
—
—
—
—
—
cases:2.44%
controls:0.31%
cases:1.42%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
12
15
480
4896
7
7
485
4904
—
—
—
—
—
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
32730-4 [3043723]
2.1e+00
2.3e+00
—
—
—
—
—
cases:2.44%
controls:0.31%
cases:1.42%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
12
15
480
4896
7
7
485
4904
—
—
—
—
—
tiotropium bromide; inhalant
R03BB04 [21603296]
R03BB04 [21603296]
1.1e+00
1.4e+00
1.2e+00
—
—
1.1e+00
8.8e-01
cases:6.10%
controls:2.22%
cases:7.32%
controls:1.98%
cases:2.44%
controls:0.77%
—
—
—
—
cases:6.16%
controls:2.13%
cases:7.14%
controls:3.08%
30
109
462
4802
36
97
456
4814
12
38
480
4873
—
—
18
103
274
4722
18
127
234
3994
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
5.2e-01
1.1e+00
3.3e+00
—
—
2.0e-01
-1.5e-01
cases:4.47%
controls:2.71%
cases:4.88%
controls:1.67%
cases:3.66%
controls:0.14%
—
—
—
—
cases:2.40%
controls:1.97%
cases:5.16%
controls:5.92%
22
133
470
4778
24
82
468
4829
18
7
474
4904
—
—
7
95
285
4730
13
244
239
3877
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
51435-6 [3029713]
2.1e+00
2.3e+00
—
—
—
—
—
cases:2.03%
controls:0.26%
cases:1.42%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
10
13
482
4898
7
7
485
4904
—
—
—
—
—
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
NK6QA [2001308500]
1.9e+00
—
—
—
—
—
2.5e+00
cases:1.83%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
cases:3.57%
controls:0.32%
9
14
483
4897
—
—
—
—
—
9
13
243
4108
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
6.0e-01
7.9e-01
1.9e+00
—
2.4e+00
4.2e-01
7.1e-01
cases:5.69%
controls:3.20%
cases:3.66%
controls:1.69%
cases:2.24%
controls:0.33%
—
—
cases:3.64%
controls:0.35%
cases:3.08%
controls:2.05%
cases:9.92%
controls:5.12%
28
157
464
4754
18
83
474
4828
11
16
481
4895
—
13
17
344
4892
9
99
283
4726
25
211
227
3910
Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
66885-5 [40769539]
66885-5 [40769539]
2.2e+00
—
1.0e+50
—
—
—
2.1e+00
cases:1.42%
controls:0.16%
—
—
cases:1.22%
controls:0.00%
—
—
—
—
—
—
cases:2.38%
controls:0.29%
7
8
485
4903
—
6
0
486
4911
—
—
—
6
12
246
4109
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
11572-5 [3021614]
1.1e+00
1.6e+00
—
—
—
1.6e+00
8.1e-01
cases:5.28%
controls:1.85%
cases:3.46%
controls:0.71%
—
—
—
—
—
—
cases:2.74%
controls:0.56%
cases:5.56%
controls:2.55%
26
91
466
4820
17
35
475
4876
—
—
—
8
27
284
4798
14
105
238
4016
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
9.2e-01
1.6e+00
—
—
—
1.8e+00
6.5e-01
cases:5.89%
controls:2.44%
cases:3.25%
controls:0.69%
—
—
—
—
—
—
cases:3.77%
controls:0.64%
cases:5.95%
controls:3.20%
29
120
463
4791
16
34
476
4877
—
—
—
11
31
281
4794
15
132
237
3989
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
6.4e-01
2.2e+00
—
1.0e+50
—
2.1e+00
7.8e-01
cases:3.05%
controls:1.63%
cases:4.47%
controls:0.53%
—
—
cases:7.32%
controls:0.00%
—
—
cases:5.14%
controls:0.66%
cases:7.14%
controls:3.40%
15
80
477
4831
22
26
470
4885
—
36
0
456
4911
—
15
32
277
4793
18
140
234
3981
salbutamol and ipratropium bromide
R03AL02 [43534844]
R03AL02 [43534844]
1.8e+00
—
—
—
—
2.2e+00
2.0e+00
cases:1.02%
controls:0.16%
—
—
—
—
—
—
—
—
cases:2.05%
controls:0.23%
cases:2.38%
controls:0.32%
5
8
487
4903
—
—
—
—
6
11
286
4814
6
13
246
4108
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
72493-0 [43055120]
2.0e+00
—
—
—
—
—
2.2e+00
cases:1.83%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:0.32%
9
12
483
4899
—
—
—
—
—
7
13
245
4108
hydroxychloroquine; oral
P01BA02 [21604889]
P01BA02 [21604889]
1.3e+00
1.4e+00
—
—
—
1.1e+00
1.6e+00
cases:3.86%
controls:1.10%
cases:3.25%
controls:0.86%
—
—
—
—
—
—
cases:2.40%
controls:0.85%
cases:5.95%
controls:1.29%
19
54
473
4857
16
42
476
4869
—
—
—
7
41
285
4784
15
53
237
4068
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
7.9e-01
2.0e+00
—
—
—
1.4e+00
5.5e-01
cases:5.28%
controls:2.46%
cases:6.10%
controls:0.90%
—
—
—
—
—
—
cases:4.11%
controls:0.99%
cases:4.76%
controls:2.81%
26
121
466
4790
30
44
462
4867
—
—
—
12
48
280
4777
12
116
240
4005
Dietary counselling and surveillance
Z71.3 [45552101]
Z71.3 [45552101]
1.8e+00
—
—
—
—
—
2.4e+00
cases:1.42%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
cases:3.17%
controls:0.29%
7
12
485
4899
—
—
—
—
—
8
12
244
4109
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
9.0e-01
1.7e+00
—
1.0e+50
—
1.5e+00
8.3e-01
cases:4.67%
controls:1.95%
cases:3.86%
controls:0.71%
—
—
cases:1.22%
controls:0.00%
—
—
cases:2.74%
controls:0.60%
cases:5.56%
controls:2.50%
23
96
469
4815
19
35
473
4876
—
6
0
486
4911
—
8
29
284
4796
14
103
238
4018
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
1.4e-01
4.4e-01
2.0e+00
—
2.2e+00
4.6e-01
1.5e-01
cases:15.24%
controls:13.52%
cases:10.16%
controls:6.82%
cases:5.28%
controls:0.77%
—
—
cases:6.72%
controls:0.81%
cases:11.30%
controls:7.46%
cases:20.63%
controls:18.25%
75
664
417
4247
50
335
442
4576
26
38
466
4873
—
24
40
333
4869
33
360
259
4465
52
752
200
3369
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
2.8e-01
1.7e+00
2.4e+00
—
—
8.4e-01
1.4e-01
cases:7.93%
controls:6.11%
cases:7.93%
controls:1.57%
cases:1.83%
controls:0.16%
—
—
—
—
cases:3.42%
controls:1.51%
cases:7.14%
controls:6.26%
39
300
453
4611
39
77
453
4834
9
8
483
4903
—
—
10
73
282
4752
18
258
234
3863
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
8.3e-01
1.1e+00
—
—
—
2.1e+00
1.1e+00
cases:5.49%
controls:2.46%
cases:1.63%
controls:0.53%
—
—
—
—
—
—
cases:2.74%
controls:0.33%
cases:5.95%
controls:1.97%
27
121
465
4790
8
26
484
4885
—
—
—
8
16
284
4809
15
81
237
4040
Insertion of central venous catheter through subclavian or brachiocephalic vein
TPH20 [2001309601]
TPH20 [2001309601]
2.2e+00
—
—
—
—
—
1.9e+00
cases:1.83%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:2.38%
controls:0.36%
9
10
483
4901
—
—
—
—
—
6
15
246
4106
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
20454-5 [3014051]
6.9e-01
1.0e+00
3.1e+00
—
—
6.3e-01
-5.9e-02
cases:4.07%
controls:2.08%
cases:4.27%
controls:1.61%
cases:4.27%
controls:0.20%
—
—
—
—
cases:3.08%
controls:1.66%
cases:5.56%
controls:5.87%
20
102
472
4809
21
79
471
4832
21
10
471
4901
—
—
9
80
283
4745
14
242
238
3879
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
5.8e-01
7.9e-01
1.8e+00
—
1.4e+00
8.6e-01
1.9e-01
cases:9.15%
controls:5.31%
cases:6.10%
controls:2.85%
cases:2.64%
controls:0.43%
—
—
cases:2.52%
controls:0.65%
cases:6.85%
controls:3.03%
cases:9.92%
controls:8.32%
45
261
447
4650
30
140
462
4771
13
21
479
4890
—
9
32
348
4877
20
146
272
4679
25
343
227
3778
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
19113-0 [3005322]
3.9e-01
1.8e+00
—
—
1.0e+50
2.2e+00
9.5e-01
cases:1.02%
controls:0.69%
cases:1.63%
controls:0.26%
—
—
—
—
cases:1.68%
controls:0.00%
cases:1.71%
controls:0.19%
cases:1.98%
controls:0.78%
5
34
487
4877
8
13
484
4898
—
—
6
0
351
4909
5
9
287
4816
5
32
247
4089
Limited function/disability NOS
A28 [2002000162]
A28 [2002000162]
4.7e-01
1.1e+00
1.5e+00
-1.0e+50
1.3e+00
1.4e+00
3.8e-01
cases:2.85%
controls:1.79%
cases:3.46%
controls:1.20%
cases:1.83%
controls:0.41%
cases:0.00%
controls:0.20%
cases:1.96%
controls:0.55%
cases:5.82%
controls:1.43%
cases:5.56%
controls:3.88%
14
88
478
4823
17
59
475
4852
9
20
483
4891
0
10
492
4901
7
27
350
4882
17
69
275
4756
14
160
238
3961
pH of Specimen
17433-4 [3019225]
17433-4 [3019225]
4.9e-01
1.4e+00
—
—
2.6e+00
1.0e+00
7.8e-01
cases:2.44%
controls:1.51%
cases:2.64%
controls:0.69%
—
—
—
—
cases:1.68%
controls:0.12%
cases:2.05%
controls:0.75%
cases:3.57%
controls:1.67%
12
74
480
4837
13
34
479
4877
—
—
6
6
351
4903
6
36
286
4789
9
69
243
4052
dexamethasone; oral, parenteral
H02AB02 [21602730]
H02AB02 [21602730]
2.1e-01
1.3e+00
2.7e+00
—
—
1.3e+00
3.6e-01
cases:2.24%
controls:1.81%
cases:3.05%
controls:0.88%
cases:1.83%
controls:0.12%
—
—
—
—
cases:2.40%
controls:0.68%
cases:3.97%
controls:2.79%
11
89
481
4822
15
43
477
4868
9
6
483
4905
—
—
7
33
285
4792
10
115
242
4006
Fever
A03 [2002000144]
A03 [2002000144]
1.1e+00
1.8e+00
—
—
—
—
1.1e+00
cases:3.05%
controls:1.08%
cases:1.83%
controls:0.31%
—
—
—
—
—
—
—
—
cases:5.95%
controls:2.01%
15
53
477
4858
9
15
483
4896
—
—
—
—
15
83
237
4038
ranitidine; oral, parenteral
A02BA02 [21600083]
A02BA02 [21600083]
1.0e+00
1.3e+00
—
—
-1.0e+50
1.7e+00
1.3e+00
cases:4.88%
controls:1.81%
cases:2.03%
controls:0.55%
—
—
—
—
cases:0.00%
controls:0.14%
cases:3.08%
controls:0.58%
cases:4.76%
controls:1.38%
24
89
468
4822
10
27
482
4884
—
—
0
7
357
4902
9
28
283
4797
12
57
240
4064
ranitidine bismuth citrate; oral
A02BA07 [21600088]
A02BA07 [21600088]
1.0e+00
1.3e+00
—
—
-1.0e+50
1.7e+00
1.3e+00
cases:4.88%
controls:1.81%
cases:2.03%
controls:0.55%
—
—
—
—
cases:0.00%
controls:0.14%
cases:3.08%
controls:0.58%
cases:4.76%
controls:1.38%
24
89
468
4822
10
27
482
4884
—
—
0
7
357
4902
9
28
283
4797
12
57
240
4064
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
3209-4 [3019250]
1.8e+00
2.2e+00
—
—
—
—
—
cases:1.63%
controls:0.26%
cases:1.22%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
8
13
484
4898
6
7
486
4904
—
—
—
—
—
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
9.8e-01
1.8e+00
—
—
—
1.3e+00
1.2e+00
cases:3.46%
controls:1.32%
cases:3.25%
controls:0.57%
—
—
—
—
—
—
cases:2.05%
controls:0.56%
cases:6.35%
controls:1.94%
17
65
475
4846
16
28
476
4883
—
—
—
6
27
286
4798
16
80
236
4041
Predominantly allergic asthma
J45.0 [45557624]
J45.0 [45557624]
8.7e-01
—
—
—
—
2.3e+00
1.7e+00
cases:1.83%
controls:0.77%
—
—
—
—
—
—
—
—
cases:2.40%
controls:0.25%
cases:3.57%
controls:0.68%
9
38
483
4873
—
—
—
—
7
12
285
4813
9
28
243
4093
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
6.1e-01
1.4e+00
2.5e+00
—
—
5.7e-01
5.8e-01
cases:3.25%
controls:1.79%
cases:3.25%
controls:0.81%
cases:2.03%
controls:0.16%
—
—
—
—
cases:1.71%
controls:0.97%
cases:4.76%
controls:2.72%
16
88
476
4823
16
40
476
4871
10
8
482
4903
—
—
5
47
287
4778
12
112
240
4009
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
104
115
11.18
88.74
2.2
1.5
—
—
—
0
0
100
109
11.24
86.11
2.2
1.5
—
—
—
0
0
56
32
19.60
69.82
2.2
1.7
—
—
—
0
0
72
79
10.49
61.05
2.1
1.6
—
—
—
0
0
76
93
9.47
59.34
2.1
1.5
—
—
—
0
0
64
71
10.20
53.66
1.9
1.6
—
—
—
0
0
56
54
11.56
51.75
2.1
1.5
—
—
—
0
0
66
86
8.70
48.76
2.0
1.6
—
—
—
0
0
64
85
8.50
46.50
2.0
1.5
—
—
—
0
0
101
216
5.62
46.48
3.8
1.9
1.13
3.31
ug/l
0.92
96
192
51
56
10.04
42.88
2.1
1.5
—
—
—
0
0
44
46
10.40
38.24
2.1
1.7
—
—
—
0
0
42
43
10.58
37.02
2.1
1.8
—
—
—
0
0
77
168
5.24
34.21
3.8
3.2
—
—
—
0
0
153
587
3.32
31.01
14.6
5.9
1.08
1.03
mmol/l
1.07
147
547
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
68
146
5.24
30.67
5.8
2.4
0.32
0.35
iu/ml
0.38
48
74
133
490
3.34
28.55
25.2
9.6
93.51
95.24
%
1.66
127
478
41
57
7.75
28.40
1.3
1.4
—
—
—
0
0
139
529
3.26
28.26
25.3
9.5
2.01
0.82
mmol/l
2.38
126
440
49
85
6.29
27.66
14.0
6.6
280.46
168.00
iu/ml
0.61
13
11
138
535
3.19
27.08
25.6
9.4
5.09
5.15
kpa
0.24
133
515
178
811
2.86
26.03
3.4
1.8
—
—
—
0
0
166
733
2.90
25.69
7.7
3.3
0.84
0.82
mmol/l
0.82
160
694
139
574
2.98
24.13
3.0
1.9
—
—
—
0
0
30
35
9.06
23.88
2.2
1.6
—
—
—
0
0
30
35
9.06
23.88
2.2
1.6
—
—
—
0
0
30
35
9.06
23.88
2.2
1.6
—
—
—
0
0
142
610
2.86
22.78
2.8
1.8
—
—
—
0
0
29
35
8.74
22.47
2.1
1.5
—
—
—
0
0
93
316
3.39
22.35
2.1
1.6
—
—
—
0
0
80
281
3.20
18.03
7.1
3.1
2.88
2.07
mmol/l
1.19
66
213
44
102
4.64
17.94
2.4
1.4
—
—
—
0
0
68
225
3.34
16.86
2.2
2.1
1.68
1.49
g/l
0.65
55
198
23
17
14.12
13.85
1.7
1.1
—
—
—
0
0
347
4156
0.45
13.77
61.6
26.7
4.19
4.47
e12/l
13.71
341
4055
347
4153
0.45
13.63
62.2
26.8
244.74
241.99
e9/l
0.30
342
4069
348
4156
0.45
13.41
61.6
26.8
8.25
6.84
e9/l
10.33
341
4057
31
69
4.73
13.25
2.2
1.4
161.00
151.72
au/ml
—
6
20
87
386
2.52
12.48
3.3
2.7
61.92
66.13
g/l
3.49
82
351
41
121
3.60
12.06
2.7
1.5
—
—
—
0
0
111
561
2.26
11.84
7.4
4.3
302.24
240.02
u/l
3.14
105
533
88
405
2.43
11.63
22.4
8.6
1.52
1.33
mmol/l
0.64
88
399
339
4045
0.49
11.59
24.0
12.5
29.27
26.18
u/l
1.95
333
3919
303
3748
0.51
11.52
36.3
17.2
76.47
77.68
ml/min/173m2
0.35
285
3505
92
442
2.33
11.00
6.6
3.6
1.65
1.80
mmol/l
0.14
80
372
319
3866
0.51
10.95
5.8
6.1
2.55
2.61
mmol/l
0.56
297
3553
21
22
9.91
10.85
2.6
1.6
—
—
—
0
0
30
78
4.03
10.55
1.5
1.2
—
—
—
0
0
21
24
9.08
10.37
2.6
1.6
—
—
—
0
0
311
3780
0.52
10.29
5.1
5.3
1.36
1.42
mmol/l
1.65
292
3461
301
3693
0.53
10.24
8.3
6.8
41.49
39.87
mmol/mol
1.96
280
3434
20
22
9.42
10.10
2.4
1.6
—
—
—
0
0
20
22
9.42
10.10
2.4
1.6
—
—
—
0
0
20
22
9.42
10.10
2.4
1.6
—
—
—
0
0
20
22
9.42
10.10
2.4
1.6
—
—
—
0
0
314
3798
0.53
10.05
5.2
5.4
4.40
4.49
mmol/l
0.83
294
3505
91
453
2.24
9.96
6.9
3.6
5.87
5.79
kpa
0.26
86
441
67
293
2.49
9.83
6.6
3.1
119.10
128.52
g/l
2.07
62
285
21
27
8.07
9.71
2.6
1.6
—
—
—
0
0
19
21
9.36
9.60
1.6
2.0
—
—
—
0
0
18
19
9.78
9.34
2.5
1.6
—
—
—
0
0
18
19
9.78
9.34
2.5
1.6
—
—
—
0
0
20
26
7.97
9.22
1.8
1.8
669.86
479.57
e6/l
0.48
14
21
18
20
9.29
9.10
2.5
1.6
—
—
—
0
0
316
3785
0.54
9.08
5.5
5.3
6.36
6.04
mmol/l
2.43
289
3448
25
64
4.06
8.98
1.4
1.3
996.05
2069.78
e6/l
1.67
20
40
27
76
3.70
8.52
1.6
1.2
192.24
297.97
u/ml
0.99
17
37
78
388
2.20
8.49
1.8
2.1
349.23
389.98
nmol/l
0.83
73
358
33
108
3.20
8.29
3.6
2.0
119.68
128.56
g/l
0.99
28
87
20
46
4.49
8.22
1.5
1.3
—
—
—
0
0
72
355
2.20
8.00
4.3
3.2
262.24
214.19
ng/l
0.26
67
324
34
121
2.94
7.42
1.7
1.6
—
—
—
0
0
61
1149
0.47
7.42
3.0
3.4
0.61
0.81
ug/l
1.43
41
769
111
673
1.84
6.86
5.0
2.5
19.79
22.11
%
1.02
104
631
308
3632
0.60
6.75
4.9
4.5
1.46
1.28
mmol/l
3.96
287
3310
99
1552
0.55
6.67
4.0
4.8
23.48
21.48
%
0.62
43
781
20
55
3.75
6.54
1.4
1.3
32467.64
27002.00
e6/l
0.09
11
27
34
132
2.69
6.35
1.4
1.2
—
—
—
0
0
61
312
2.09
6.16
7.6
4.1
135.49
86.59
ng/l
2.43
55
277
337
3861
0.60
6.10
49.0
17.8
38.23
26.46
mg/l
6.37
321
3220
140
936
1.69
6.09
3.2
1.7
2.01
1.55
mg/l
0.80
125
741
250
1931
1.59
6.07
24.7
6.9
1.19
1.21
mmol/l
3.99
239
1771
14
21
6.83
6.07
2.9
5.6
—
—
—
0
0
26
90
2.99
5.98
1.5
1.2
—
—
—
0
0
31
119
2.71
5.92
1.6
1.3
—
—
—
0
0
26
92
2.93
5.76
1.4
1.3
—
—
—
0
0
76
432
1.90
5.69
2.7
2.4
0.21
0.21
g/l
0.03
71
400
29
110
2.74
5.67
1.9
1.4
—
—
—
0
0
119
777
1.70
5.60
4.9
2.5
10.38
12.61
umol/l
3.38
113
730
35
148
2.47
5.53
2.4
1.6
3.67
9.34
iu/ml
—
10
39
112
725
1.70
5.43
5.1
2.5
2.12
2.26
g/l
1.66
104
674
243
1900
1.55
5.37
11.5
5.2
31.23
35.25
g/l
14.39
233
1777
307
3562
0.64
5.34
5.5
5.0
2.14
1.98
mu/l
0.94
287
3228
279
2251
1.55
5.33
12.7
6.9
10.24
12.09
umol/l
4.13
273
2155
87
528
1.79
5.28
3.6
3.0
5.00
8.26
umol/l
3.69
76
476
16
35
4.69
5.22
1.3
1.1
—
—
—
0
0
18
54
3.42
5.21
1.2
1.2
1.17
3.24
u/ml
—
6
17
17
50
3.49
5.07
2.7
4.1
—
—
—
0
0
143
1940
0.63
5.06
4.3
5.9
1.69
2.78
ug/l
3.51
122
1733
24
88
2.82
5.01
1.9
1.4
—
—
—
0
0
24
88
2.82
5.01
1.9
1.4
—
—
—
0
0
10
13
7.82
4.87
2.9
2.3
71.09
104.29
ug/l
—
10
13
18
57
3.24
4.81
1.0
1.2
—
—
—
0
0
36
166
2.26
4.72
1.4
2.3
41.30
38.53
u/l
0.20
30
147
184
1385
1.52
4.67
4.9
3.3
41.62
34.64
u/l
0.94
175
1306
13
26
5.10
4.66
1.6
1.7
—
—
—
0
0
13
26
5.10
4.66
1.6
1.7
—
—
—
0
0
33
149
2.30
4.54
4.9
3.5
7.82
3.26
ratio
0.30
25
84
11
19
5.90
4.46
2.5
2.3
1477.91
783.16
u/ml
0.55
11
19
57
325
1.85
4.23
2.0
1.4
—
—
—
0
0
14
41
3.48
4.21
1.2
1.1
—
—
—
0
0
114
787
1.58
4.21
2.0
1.7
1112.59
1178.07
nmol/l
0.37
88
605
36
175
2.14
4.17
10.2
3.6
25.83
25.08
mmol/l
0.81
36
162
10
17
5.98
4.15
2.5
3.1
112.30
94.76
%
—
10
17
8
10
8.11
4.07
1.1
1.0
—
—
—
0
0
8
10
8.11
4.07
1.9
1.4
—
—
—
0
0
99
670
1.60
3.96
1.6
1.3
38.80
27.83
iu/ml
0.62
35
212
122
1647
0.66
3.94
2.3
2.0
1.58
1.30
mmol/l
2.45
109
1368
14
43
3.32
3.93
1.7
2.8
576.36
1489.51
mg
1.04
14
43
8
11
7.37
3.87
10.6
10.3
4.61
4.77
kpa
—
8
11
7
8
8.85
3.78
1.0
1.8
—
—
—
0
0
16
55
2.97
3.77
1.9
1.4
—
—
—
0
0
16
55
2.97
3.77
1.9
1.4
—
—
—
0
0
16
55
2.97
3.77
1.9
1.4
—
—
—
0
0
276
2319
1.43
3.72
18.7
9.8
5.37
4.21
e9/l
8.22
252
2010
257
2132
1.43
3.72
22.4
16.1
1.34
1.31
inr
0.44
222
1779
36
184
2.03
3.68
4.1
1.7
—
—
—
0
0
16
56
2.92
3.66
1.9
1.4
—
—
—
0
0
16
57
2.87
3.55
1.9
1.4
—
—
—
0
0
16
57
2.87
3.55
1.9
1.4
—
—
—
0
0
257
2144
1.41
3.54
25.9
7.6
1.20
1.21
mmol/l
2.32
231
1846
24
106
2.33
3.51
1.5
1.3
—
—
—
0
0
162
1257
1.43
3.31
5.2
3.4
0.51
0.56
e6/l
0.14
131
931
42
237
1.84
3.25
2.2
1.5
—
—
—
0
0
9
19
4.80
3.25
1.0
1.1
—
—
—
0
0
70
457
1.62
3.24
6.2
3.5
—
—
—
0
0
183
1456
1.41
3.24
4.3
3.3
2794.50
1659.99
ng/l
1.19
169
1251
7
11
6.44
3.19
1.1
1.2
—
—
—
0
0
17
67
2.59
3.16
2.1
2.2
29.29
33.19
pg
1.47
17
67
149
1157
1.41
2.99
3.1
2.3
3.18
2.95
mg/l
0.58
131
1003
11
32
3.49
2.91
1.6
1.3
—
—
—
0
0
15
58
2.64
2.90
1.3
1.1
2.50
8.45
u/ml
—
6
22
10
27
3.76
2.89
2.3
1.9
—
—
—
0
0
24
116
2.12
2.87
1.7
1.5
238.06
293.08
ug/g
0.53
15
66
31
167
1.91
2.78
3.1
1.6
—
—
—
0
0
6
10
6.06
2.70
12.0
10.7
9.07
10.74
%
—
6
10
10
30
3.38
2.61
1.1
1.0
—
—
—
0
0
86
620
1.47
2.56
1.5
1.3
15.72
7.58
u/ml
0.48
28
226
168
1361
1.35
2.55
3.4
2.2
347.24
265.60
u/l
0.25
161
1283
6
11
5.50
2.55
1.2
1.0
1648.67
1304.73
miu/ml
—
6
11
6
11
5.50
2.55
1.5
1.2
—
—
—
0
0
178
1461
1.34
2.47
5.4
3.5
52.84
103.19
e6/l
0.48
148
1128
129
1011
1.37
2.40
3.9
2.6
4.75
4.64
e6/l
0.05
122
922
5
8
6.30
2.37
1.2
1.3
—
—
—
0
0
13
52
2.54
2.37
1.2
1.1
—
—
—
0
0
16
326
0.47
2.34
2.1
2.1
3.50
3.52
ratio
0.02
11
272
116
899
1.38
2.31
6.6
4.2
754.01
352.01
ng/l
0.38
102
751
11
40
2.79
2.28
1.0
1.3
—
—
—
0
0
14
60
2.37
2.23
3.4
7.4
7.00
6.92
mmol/l
0.06
14
50
60
415
1.51
2.19
4.6
2.6
39.04
34.51
u/l
0.39
49
352
18
89
2.06
2.08
1.2
1.4
146.08
271.68
miu/ml
—
5
40
6
15
4.04
2.04
1.7
1.1
—
—
—
0
0
11
44
2.53
2.02
2.9
2.0
2.11
0.56
mmol/l
0.56
11
44
8
26
3.11
2.02
3.0
1.2
—
—
—
0
0
9
32
2.85
2.01
6.0
3.1
0.56
0.84
index
—
9
32
35
540
0.62
2.00
5.8
5.1
30.00
31.49
%
0.52
30
344
7
21
3.37
1.97
1.1
1.1
—
—
—
0
0
45
300
1.55
1.96
2.1
1.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
11
4.58
1.94
1.6
3.1
329.46
130.18
%
—
5
11
7
22
3.21
1.88
1.0
1.2
80.86
19.35
u/l
—
7
17
263
2918
0.79
1.85
4.4
4.0
14.87
14.84
pmol/l
0.07
241
2620
7
23
3.07
1.80
1.0
1.2
121.57
82.94
u/l
—
7
18
8
29
2.79
1.80
1.9
1.3
—
—
—
0
0
8
29
2.79
1.80
1.3
3.6
1.00
0.90
%
—
8
29
48
333
1.49
1.76
9.6
3.9
1.20
1.23
mmol/l
2.64
43
286
7
24
2.94
1.73
2.0
1.3
—
—
—
0
0
7
24
2.94
1.73
2.0
1.3
—
—
—
0
0
55
397
1.43
1.66
3.0
2.5
7.93
7.69
ug/l
0.02
47
351
13
63
2.09
1.61
1.2
1.4
—
—
—
0
0
186
2117
0.81
1.53
6.1
3.9
0.00
0.00
estimate
-0.00
46
445
236
2616
0.81
1.50
5.7
3.4
103.22
54.07
u/l
2.29
223
2455
19
109
1.77
1.49
1.5
1.6
—
—
—
0
0
7
28
2.52
1.45
2.0
1.3
—
—
—
0
0
7
29
2.43
1.39
2.0
1.3
—
—
—
0
0
27
175
1.57
1.37
1.5
1.5
0.23
0.31
mg/l
—
10
81
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
17
98
1.76
1.32
1.1
1.1
—
—
—
0
0
13
230
0.55
1.30
1.8
1.9
3.65
3.48
mmol/l
—
8
175
193
2161
0.83
1.29
6.5
4.0
0.00
0.72
estimate
0.51
42
424
57
436
1.35
1.26
2.1
1.8
2.07
1.55
%
1.91
50
376
10
49
2.06
1.22
2.5
2.7
—
—
—
0
0
8
38
2.12
1.19
1.1
1.2
—
—
—
0
0
165
1449
1.21
1.18
6.2
3.5
2.31
2.35
mmol/l
1.97
152
1299
5
21
2.39
1.09
1.2
1.1
—
—
—
0
0
193
2136
0.84
1.08
6.3
4.0
23.69
3.60
estimate
0.39
48
451
7
32
2.20
1.08
1.1
1.2
90.71
95.69
pmol/l
—
7
32
271
2505
1.18
1.06
20.0
5.5
7.55
6.77
mmol/l
5.56
266
2385
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
22
2.29
1.03
1.2
1.2
—
—
—
0
0
7
34
2.07
1.03
1.0
1.1
—
—
—
0
0
142
1607
0.84
1.02
6.0
3.9
0.07
0.01
estimate
0.55
42
377
7
35
2.01
1.00
1.6
1.2
—
—
—
0
0
13
76
1.73
0.99
9.3
3.3
12.26
8.74
pmol/l
0.54
13
76
13
76
1.73
0.99
1.6
1.2
147.58
31.25
u/l
0.44
13
65
93
784
1.23
0.99
4.7
3.2
1.71
0.98
e6/l
0.67
55
434
9
49
1.85
0.99
6.3
3.3
13.44
12.28
index
—
9
32
130
1139
1.19
0.94
6.8
2.9
361.74
358.87
umol/l
0.10
110
994
18
118
1.55
0.92
1.4
1.3
—
—
—
0
0
22
151
1.48
0.92
1.1
1.3
—
—
—
0
0
6
29
2.08
0.89
1.2
1.1
—
—
—
0
0
6
31
1.95
0.84
1.2
1.1
—
—
—
0
0
6
31
1.95
0.84
1.2
1.1
—
—
—
0
0
6
31
1.95
0.84
1.2
1.2
—
—
—
0
0
15
98
1.55
0.79
1.1
1.1
—
—
—
0
0
104
908
1.18
0.79
1.8
1.8
551.38
5284447.43
pmol/l
0.50
84
757
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
43
345
1.27
0.73
4.0
2.8
60.70
65.89
ml/min/173m2
0.27
23
150
202
2178
0.88
0.73
3.3
2.8
—
—
—
0
0
9
59
1.53
0.68
10.7
2.0
12.44
10.56
mmol/l
—
9
59
7
43
1.64
0.67
1.1
1.1
—
—
—
0
0
285
2995
0.89
0.65
7.7
4.2
22.34
12.71
mm/h
9.61
276
2762
5
29
1.73
0.64
2.8
1.6
62.00
84.55
umol/l
—
5
29
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
109
1204
0.88
0.56
6.1
3.9
0.00
0.01
estimate
0.78
44
405
84
744
1.16
0.55
5.3
3.3
1.78
1.70
e6/l
0.05
45
397
9
136
0.66
0.52
2.4
1.9
25.67
41.68
nmol/l
—
9
127
6
40
1.51
0.51
1.5
1.5
29.82
27.56
u/l
—
6
35
6
40
1.51
0.51
1.2
1.1
—
—
—
0
0
105
1155
0.88
0.51
5.5
3.4
0.00
0.08
estimate
0.60
40
350
33
399
0.81
0.50
1.2
1.5
—
—
—
0
0
116
1060
1.12
0.49
5.1
2.6
—
—
—
0
0
27
217
1.26
0.49
1.2
1.2
28.04
133.99
u/ml
—
8
85
189
1776
1.10
0.48
3.6
2.4
72.40
77.39
nmol/l
1.94
175
1561
93
843
1.13
0.45
1.3
1.2
2.81
1.31
u/ml
0.55
28
235
6
91
0.66
0.42
1.3
3.6
3617.32
478.98
u/ml
—
6
83
5
32
1.57
0.42
1.6
1.5
—
—
—
0
0
0
17
0.00
0.40
0.0
2.5
—
42.05
—
0
17
0
17
0.00
0.40
0.0
1.2
—
9.24
—
0
17
8
112
0.71
0.37
1.0
1.1
1.47
1.55
g/l
—
8
112
6
46
1.31
0.33
1.0
1.2
—
—
—
0
0
194
1853
1.08
0.33
5.8
3.0
325.41
138.35
ug/l
2.90
182
1714
49
546
0.89
0.31
1.4
1.5
—
—
—
0
0
124
1315
0.92
0.30
2.0
1.8
17.73
20.40
nmol/l
1.56
112
1092
7
57
1.23
0.29
1.9
1.6
—
—
—
0
0
9
118
0.76
0.27
1.0
1.1
0.97
0.89
g/l
—
9
118
184
1913
0.94
0.26
2.6
2.2
92.80
94.35
pmol/l
0.22
115
1036
0
11
0.00
0.21
0.0
2.2
—
2.37
—
0
6
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
6
50
1.20
0.19
1.2
1.1
—
1.32
—
0
9
23
259
0.88
0.19
2.0
1.8
—
—
—
0
0
26
284
0.91
0.14
2.1
1.9
—
—
—
0
0
178
1740
1.04
0.12
6.8
4.1
79.60
47.60
ng/l
0.49
155
1313
5
44
1.14
0.10
1.4
1.3
—
—
—
0
0
143
1461
0.97
0.09
5.4
4.0
28.60
9.97
mg/mmol
1.23
102
923
12
134
0.89
0.09
1.6
1.8
3.06
4.29
mg/l
0.30
12
104
12
107
1.12
0.08
1.4
1.3
—
—
—
0
0
16
174
0.92
0.07
1.2
1.0
—
—
—
0
0
9
100
0.90
0.06
1.3
1.7
—
—
—
0
0
311
3134
0.98
0.06
17.5
8.4
89.53
79.98
u/l
2.77
304
2945
196
1937
1.02
0.06
5.3
2.9
—
—
estimate
—
0
0
46
476
0.96
0.06
16.1
7.4
—
—
—
0
0
148
1468
1.01
0.02
4.4
3.3
6.70
7.78
mmol/l
2.61
130
1215
10
104
0.96
0.00
1.8
1.9
—
—
—
0
0
13
126
1.03
0.00
1.6
2.0
—
—
—
0
0
48
485
0.99
0.00
2.7
4.4
4.81
39.26
ug/l
1.30
42
402
92
924
0.99
0.00
6.2
4.2
15.27
1.02
kg/l
0.49
71
627
88
876
1.01
0.00
3.1
3.1
2.49
2.45
mmol/l
1.56
79
784
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.9
—
85.67
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
—
—
0
0
8
79
1.01
-0.00
1.4
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.43
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
21.33
—
0
9
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint J10_ARDS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_ARDS | 4.114 [2.99, 5.67] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.123 |
During the follow-up period (1.1.1998 — 31.12.2019), 380 out of 840 females with J10_ARDS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_ARDS | 3.869 [3.11, 4.82] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.02 |
During the follow-up period (1.1.1998 — 31.12.2019), 581 out of 1115 males with J10_ARDS died.
Mortality risk
Mortality risk for people of age
years, who have J10_ARDS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.343% | 0.847% |
| 5 | 2.574% | 4.935% |
| 10 | 6.118% | 11.15% |
| 15 | 11.445% | 19.998% |
| 20 | 18.726% | 31.948% |
Relationships between endpoints
↥Index endpoint: J10_ARDS – Adult respiratory distress syndrome
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data